PMC accession number (PMCID),Paragraph,IUPAC name,SMILES,1H NMR text,13C NMR text,1H NMR conditions,1H NMR chemical shifts,13C NMR conditions,13C NMR chemical shifts,PMID,Article Citation,Journal Name,Article publication time,License,LastUpdated (YYYY-MM-DD HH:MM:SS),Retracted
PMC2981938,"2-(Phenylethynyl)triphenylene (1a). The crude product was purified by column chromatography with hexane as eluant to afford 1a as a colorless solid (0.495 g, 80%), mp 180–182 °C; IR (neat) 3069, 2217 cm−1; 1H NMR (CDCl3, 500 MHz) δH = 8.80 (d, J = 1.5 Hz, 1H), 8.55–8.64 (m, 5H), 7.75 (dd, J = 1.5, 8.5 Hz, 1H), 7.61–7.66 (m, 6H), 7.36-7.40 (m, 3H) ppm; 13C NMR (CDCl3, 125 MHz) δc 131.7, 130.1, 130.0, 129.9, 129.7, 129.6, 129.3, 129.1, 128.5, 128.4, 127.59, 127.58, 127.4, 127.3, 126.8, 123.5, 123.43, 123.41, 123.36, 123.31, 121.9, 90.2, 89.9 ppm; The mass spectrum was recorded as the silver ion adduct of 1a by adding silver triflate to a solution of 1a in acetonitrile prior to measurement. ESI Q-TOF MS m/z 435 [M + Ag]+ along with the isotope peaks in the expected intensity ratios; HRMS calcd for C26H16Ag [M + Ag]+ 435.0303; found, 435.0298.",2-(Phenylethynyl)triphenylene,C1(C#CC2=CC=CC=C2)=CC=C3C4=CC=CC=C4C5=CC=CC=C5C3=C1,"1H NMR (CDCl3, 500 MHz) δH = 8.80 (d, J = 1.5 Hz, 1H), 8.55–8.64 (m, 5H), 7.75 (dd, J = 1.5, 8.5 Hz, 1H), 7.61–7.66 (m, 6H), 7.36-7.40 (m, 3H) ppm","13C NMR (CDCl3, 125 MHz) δc 131.7, 130.1, 130.0, 129.9, 129.7, 129.6, 129.3, 129.1, 128.5, 128.4, 127.59, 127.58, 127.4, 127.3, 126.8, 123.5, 123.43, 123.41, 123.36, 123.31, 121.9, 90.2, 89.9 ppm","CDCl3, 500 MHz","8.80 (d, J = 1.5 Hz, 1H), 8.55–8.64 (m, 5H), 7.75 (dd, J = 1.5, 8.5 Hz, 1H), 7.61–7.66 (m, 6H), 7.36-7.40 (m, 3H)","CDCl3, 125 MHz","131.7, 130.1, 130.0, 129.9, 129.7, 129.6, 129.3, 129.1, 128.5, 128.4, 127.59, 127.58, 127.4, 127.3, 126.8, 123.5, 123.43, 123.41, 123.36, 123.31, 121.9, 90.2, 89.9",21085512.0,Beilstein J Org Chem. 2010 Oct 18; 6:992-1001,Beilstein J Org Chem,2010.0,CC BY,2021-02-23 23:15:00,no
PMC9312894,"Methyl 2-(2-((2-chlorophenyl)carbamoyl)phenoxy)acetate (ME2).Yield (%): 65, m.p. (°C): 85–87. IR ν(cm−1) KBr pellet: 3345m (νNH free sec. amide); 3082s (νCH aromatic); 1751i (νC=O ester); 1678i (νC=O amide); 1596i(Sk “1600”); 1541i (γNH + νCN sec. amide); 1486m, 1457i, 1437m (Sk “1500”, σasCH3 ester); 1377m (σCH aromatic); 1308m (νasCOC aromatic); 1240m (γCN + νNH sec. amide); 1200i (νasCOC aliphatic); 1067m (νsCOC aromatic); 747i (Sk“700”, aromatic nucleus 1,2-disubstituted). 1H-NMR [δ(ppm)]: 3.71 (s, 3H, -CH3); 5.20 (s, 2H, Ar-OCH2); 7.19–7.25 (m, 3H, H3, H5, H10); 7.39 (t, 1H, H11, J = 8.0); 7.56 (d, 1H, H9); 7.58 (t, 2H, H4); 8.06 (d, 1H, H12, J = 8.0); 8.29 (d, 1H, H2, J = 8.0); 10.40 (s, 1H, -NH-). 13C-NMR [δ(ppm)]: 52.21 (-CH3); 65.57 (Ar-OCH2-); 113.62 (C5); 121.64 (C1); 122.06 (C3); 123.56 (C12); 124.32 (C10); 125.63 (C8); 127.77 (C11); 129.40 (C2); 131.60 (C9); 133.73 (C4); 135.08 (C7); 155.55 (C6); 162.80 (Ar-CO); 168.92 (-COO-).",Methyl 2-(2-((2-chlorophenyl)carbamoyl)phenoxy)acetate,O=C(OC)COC1=CC=CC=C1C(NC2=CC=CC=C2Cl)=O,"1H-NMR [δ(ppm)]: 3.71 (s, 3H, -CH3); 5.20 (s, 2H, Ar-OCH2); 7.19–7.25 (m, 3H, H3, H5, H10); 7.39 (t, 1H, H11, J = 8.0); 7.56 (d, 1H, H9); 7.58 (t, 2H, H4); 8.06 (d, 1H, H12, J = 8.0); 8.29 (d, 1H, H2, J = 8.0); 10.40 (s, 1H, -NH-)",13C-NMR [δ(ppm)]: 52.21 (-CH3); 65.57 (Ar-OCH2-); 113.62 (C5); 121.64 (C1); 122.06 (C3); 123.56 (C12); 124.32 (C10); 125.63 (C8); 127.77 (C11); 129.40 (C2); 131.60 (C9); 133.73 (C4); 135.08 (C7); 155.55 (C6); 162.80 (Ar-CO); 168.92 (-COO-),N/A,"3.71 (s, 3H, -CH3), 5.20 (s, 2H, Ar-OCH2), 7.19–7.25 (m, 3H, H3, H5, H10), 7.39 (t, 1H, H11, J = 8.0), 7.56 (d, 1H, H9), 7.58 (t, 2H, H4), 8.06 (d, 1H, H12, J = 8.0), 8.29 (d, 1H, H2, J = 8.0), 10.40 (s, 1H, -NH-)",N/A,"52.21, 65.57, 113.62, 121.64, 122.06, 123.56, 124.32, 125.63, 127.77, 129.40, 131.60, 133.73, 135.08, 155.55, 162.80, 168.92",35885043.0,Biomedicines. 2022 Jul 19; 10(7):1740,Biomedicines,2022.0,CC BY,2022-07-26 23:23:27,no
PMC6255260,"3.5. Isolation of chysoeriol-7-O-rutinoside by preparative liquid chromatography Air dried plant material (500 g) was extracted with 1500 ml of methanol at 60 °C. Filtrated extract was evaporated to dryness and dissolved in 200 ml of methanol-water (1:1, v/v). Chlorophyll was removed by extraction with chloroform. Purified extract was evaporated under reduced pressure until methanol is removed. The water layer was partitioned against ethyl acetate. The ethyl acetate extract was again partitioned against water. This water extract was evaporated to dryness, dissolved in methanol and applied on silica gel 60, 20 x 20 cm, 1.0 mm thin layer TLC plates as a 15 cm band. The plate was developed using 100:25:10:10:11 (v/v/v/v/v) ethyl acetate-dichloromethane-formic acid-acetic acid-water The chromatographic band (RF=0.13) expected to contain the compound was scraped off and extracted with methanol. To purify the compound, preparative liquid chromatography was done once more using ethyl acetate-methanol-formic acid-water (100:13.5:2.5:10, v/v/v/v) as mobile phase and the same stationary phase. Purified compound (RF=0.25) was again extracted with methanol, filtered through 0.45 µm filter, evaporated to dryness, redissolved in methanol and checked for purity by HPLC-DAD-MS. UV λMeOH max (nm) 267, 272 sh, 342; + NaOMe 270, 277 sh, 391; +AlCl3 273, 297 sh, 347, 394; +AlCl3 - HCl 275, 297 sh, 349, 390 nm; + NaOAc 269, 346; +NaOAc - H3BO3 269, 350; IR νmax (KBr) 3400, 2958, 2831, 2790, 2716, 1600, 1412, 1360, 1148, 1115 cm-1; 1H-NMR: δ 1.97 (3H, d, J5''', 6''' = 8.6 Hz, H-6'''), 3.09 (2H, m, H-5'', H-5'''), 3.17 (2H, m, H-2'', H-3''), 3.21 (2H, m, H-4'', H-4'''), 3.32 (3H, s, H-7'), 3.88 (2H, m, H-2''', H-3'''), 3.90 (1H, m, H-6a''), 3.93 (1H, m, H-6b''), 4.26 (1H, d, J1'', 2'' = 4.7 Hz, H-1'''), 4.85-5.11 (8H, m, OH -5, -4', -2'', -3'', -4'', -2''', -3''', -4'''), 6.79 (1H, s, H-6), 6.86 (1H, s, H-3), 7.03 (1H, s, H-8), 7.10 (1H, d, J5', 6' = 0.99, H-5'), 7.28 (1H, d, J5', 6' = 0.38 Hz, H-6'), 7.29 (1H, s, H-2'); 13C-NMR: δ 22.4 (C-6'''), 47.8 (C-7'), 69.4 (C-6''), 69.5 (C-5'''), 69.7 (C-4''), 69.8 (C-2'''), 69.9 (C-3'''), 70.0 (C-4'''), 70.1 (C-2''), 70.9 (C-5''), 71.0 (C-3''), 94.7 (C-8), 96.8 (C-1''), 98.0 (C-6), 101.2 (C-1'''), 105.6 (C-3), 106.1 (C-10), 109.6 (C-2'), 118.76 (C-5'), 121.0 (C-6'), 131.42 (C-1'), 144.7 (C-4'), 150.8 (C-3'), 157.8 (C-9), 161.9 (C-5), 164.6 (C-2), 167.6 (C-7), 181.3 (C-4).  4. Conclusions",chysoeriol-7-O-rutinoside,N/A,"1H-NMR: δ 1.97 (3H, d, J5''', 6''' = 8.6 Hz, H-6'''), 3.09 (2H, m, H-5'', H-5'''), 3.17 (2H, m, H-2'', H-3''), 3.21 (2H, m, H-4'', H-4'''), 3.32 (3H, s, H-7'), 3.88 (2H, m, H-2''', H-3'''), 3.90 (1H, m, H-6a''), 3.93 (1H, m, H-6b''), 4.26 (1H, d, J1'', 2'' = 4.7 Hz, H-1'''), 4.85-5.11 (8H, m, OH -5, -4', -2'', -3'', -4'', -2''', -3''', -4'''), 6.79 (1H, s, H-6), 6.86 (1H, s, H-3), 7.03 (1H, s, H-8), 7.10 (1H, d, J5', 6' = 0.99, H-5'), 7.28 (1H, d, J5', 6' = 0.38 Hz, H-6'), 7.29 (1H, s, H-2')","13C-NMR: δ 22.4 (C-6'''), 47.8 (C-7'), 69.4 (C-6''), 69.5 (C-5'''), 69.7 (C-4''), 69.8 (C-2'''), 69.9 (C-3'''), 70.0 (C-4'''), 70.1 (C-2''), 70.9 (C-5''), 71.0 (C-3''), 94.7 (C-8), 96.8 (C-1''), 98.0 (C-6), 101.2 (C-1'''), 105.6 (C-3), 106.1 (C-10), 109.6 (C-2'), 118.76 (C-5'), 121.0 (C-6'), 131.42 (C-1'), 144.7 (C-4'), 150.8 (C-3'), 157.8 (C-9), 161.9 (C-5), 164.6 (C-2), 167.6 (C-7), 181.3 (C-4)",N/A,"1.97 (3H, d, J5''', 6''' = 8.6 Hz, H-6'''), 3.09 (2H, m, H-5'', H-5'''), 3.17 (2H, m, H-2'', H-3''), 3.21 (2H, m, H-4'', H-4'''), 3.32 (3H, s, H-7'), 3.88 (2H, m, H-2''', H-3'''), 3.90 (1H, m, H-6a''), 3.93 (1H, m, H-6b''), 4.26 (1H, d, J1'', 2'' = 4.7 Hz, H-1'''), 4.85-5.11 (8H, m, OH -5, -4', -2'', -3'', -4'', -2''', -3''', -4'''), 6.79 (1H, s, H-6), 6.86 (1H, s, H-3), 7.03 (1H, s, H-8), 7.10 (1H, d, J5', 6' = 0.99, H-5'), 7.28 (1H, d, J5', 6' = 0.38 Hz, H-6'), 7.29 (1H, s, H-2')",N/A,"22.4, 47.8, 69.4, 69.5, 69.7, 69.8, 69.9, 70.0, 70.1, 70.9, 71.0, 94.7, 96.8, 98.0, 101.2, 105.6, 106.1, 109.6, 118.76, 121.0, 131.42, 144.7, 150.8, 157.8, 161.9, 164.6, 167.6, 181.3",19633617.0,Molecules. 2009 Jul 9; 14(7):2466-2490,Molecules,2009.0,CC BY,2021-01-05 21:51:16,no
PMC8198214,"To a solution of 2-((S)-5-bromo-2′,4′-dioxo-2,3-dihydrospiro[indene-1,5′-oxazolidin]-3′-yl)-N-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)methyl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide (85, 0.26 g, 0.43 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (0.099 g, 0.48 mmol) and Pd(dppf)Cl2 (0.031 g, 0.043 mmol) in 1,4-dioxane (5 mL) was added a saturated solution of sodium bicarbonate (0.5 mL) under nitrogen. The mixture was stirred in 85 °C until completion, cooled to room temperature, concentrated, and purified directly by silica gel column chromatography to afford B1 (0.068 g, 26%). 1H-NMR (CDCl3) δ 7.75 (s, 1H), 7.61 (s, 1H), 7.51 − 7.43 (m, 1H), 7.43 − 7.37 (m, 2H), 7.14 − 7.08 (m, 1H), 7.06 (s, 1H), 6.97 − 6.90 (m, 1H), 5.63 − 5.40 (m, 1H), 4.74 − 4.62 (m, 2H), 4.47 − 4.39 (m, 1H), 4.26 − 4.20 (m, 1H), 3.94 (s, 3H), 3.31 − 3.20 (m, 1H), 3.19 − 3.08 (m, 1H), 2.85 − 2.74 (m, 1H), 2.63 − 2.50 (m, 1H), 1.32 (s, 3H). 13C-NMR (CDCl3) δ 174.26, 174.10, 166.87, 154.37, 146.02, 144.60, 143.44, 136.96, 135.61, 134.90, 131.99, 131.67, 127.35, 125.29, 124.85, 123.72 (q, J = 214 Hz), 121.84, 120.66, 110.18, 107.13, 94.82, 50.61, 46.21, 41.66, 39.18, 35.40, 30.27, 11.59. HPLC: retention time 13.762 min, 96.37% purity. HRMS (ESI): m/z calcd for C28H23F5N4O6, 607.1611, found 607.1627 [M + H]+.",B1,N/A,"1H-NMR (CDCl3) δ 7.75 (s, 1H), 7.61 (s, 1H), 7.51 − 7.43 (m, 1H), 7.43 − 7.37 (m, 2H), 7.14 − 7.08 (m, 1H), 7.06 (s, 1H), 6.97 − 6.90 (m, 1H), 5.63 − 5.40 (m, 1H), 4.74 − 4.62 (m, 2H), 4.47 − 4.39 (m, 1H), 4.26 − 4.20 (m, 1H), 3.94 (s, 3H), 3.31 − 3.20 (m, 1H), 3.19 − 3.08 (m, 1H), 2.85 − 2.74 (m, 1H), 2.63 − 2.50 (m, 1H), 1.32 (s, 3H)","13C-NMR (CDCl3) δ 174.26, 174.10, 166.87, 154.37, 146.02, 144.60, 143.44, 136.96, 135.61, 134.90, 131.99, 131.67, 127.35, 125.29, 124.85, 123.72 (q, J = 214 Hz), 121.84, 120.66, 110.18, 107.13, 94.82, 50.61, 46.21, 41.66, 39.18, 35.40, 30.27, 11.59",CDCl3,"7.75 (s, 1H), 7.61 (s, 1H), 7.51 − 7.43 (m, 1H), 7.43 − 7.37 (m, 2H), 7.14 − 7.08 (m, 1H), 7.06 (s, 1H), 6.97 − 6.90 (m, 1H), 5.63 − 5.40 (m, 1H), 4.74 − 4.62 (m, 2H), 4.47 − 4.39 (m, 1H), 4.26 − 4.20 (m, 1H), 3.94 (s, 3H), 3.31 − 3.20 (m, 1H), 3.19 − 3.08 (m, 1H), 2.85 − 2.74 (m, 1H), 2.63 − 2.50 (m, 1H), 1.32 (s, 3H)",CDCl3,"174.26, 174.10, 166.87, 154.37, 146.02, 144.60, 143.44, 136.96, 135.61, 134.90, 131.99, 131.67, 127.35, 125.29, 124.85, 123.72, 121.84, 120.66, 110.18, 107.13, 94.82, 50.61, 46.21, 41.66, 39.18, 35.40, 30.27, 11.59",34070610.0,Molecules. 2021 May 25; 26(11):3162,Molecules,2021.0,CC BY,2021-09-02 23:44:21,no
PMC10095016,"The resulting product, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-3-sulfanylpropanamide (AZM-SH, FW = 268.34), was dried at 37 °C and collected in the form of brownish-white powder (70.4% wt. yield, mp 203.6 ± 1.0 °C), ESI+QTOF MS: [C5H8N4O3S3+H]+ 268.9831 m/z (error—2.5 ppm) and [C5H8N4O3S3-H]+ 266.9853 m/z (error—2.2 ppm). Elemental analysis of C5H8N4O3S3 was found (calculated): C 21.64% (22.38%), H 2.28% (3.00%); N 17.41% (20.88%), S 29.66% (35.85%). 1H NMR spectrum (CD3CN, 400 MHz) δ (ppm): 1.30 (s, 1H, H1 -SH) 2.70–2.97 (dt, 2H, H2 -CH2), 3.23–3.37 (dt, 2H, H3-CH2), 6.43 (d, 2H, H13-NH2, J = 33.8 Hz), 10.62 (br s, H, H6-NH-). 13C NMR spectrum (DMSO-d6, 400 MHz) δ (ppm): 24.04 (C1), 34.56 (C2), 161.29 (C3), 164.94 (C4), 170.78 (C5). The product was also characterized using ATR-FTIR.  3.3.2. Synthesis of NANO3-SH","N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-3-sulfanylpropanamide",O=C(NC1=NN=C(S(=O)(N)=O)S1)CCS,"1H NMR spectrum (CD3CN, 400 MHz) δ (ppm): 1.30 (s, 1H, H1 -SH) 2.70–2.97 (dt, 2H, H2 -CH2), 3.23–3.37 (dt, 2H, H3-CH2), 6.43 (d, 2H, H13-NH2, J = 33.8 Hz), 10.62 (br s, H, H6-NH-)","13C NMR spectrum (DMSO-d6, 400 MHz) δ (ppm): 24.04 (C1), 34.56 (C2), 161.29 (C3), 164.94 (C4), 170.78 (C5)","CD3CN, 400 MHz","1.30 (s, 1H, H1 -SH) 2.70–2.97 (dt, 2H, H2 -CH2), 3.23–3.37 (dt, 2H, H3-CH2), 6.43 (d, 2H, H13-NH2, J = 33.8 Hz), 10.62 (br s, H, H6-NH-)","DMSO-d6, 400 MHz","24.04, 34.56, 161.29, 164.94, 170.78",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC9080005,"1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrole-3-carbaldehyde (5j) Yellow pasty liquid (85 mg, 78%); 1H NMR (400 MHz, CDCl3) δ 3.81 (s, 3H), 6.84 (d, J = 9.0 Hz, 2H), 6.89 (d, J = 3.1 Hz, 1H), 6.92 (d, J = 3.0 Hz, 1H), 7.02 (d, J = 8.9 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H), 9.70 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 55.4, 108.3, 114.5 (2C), 124.9, 125.1, 125.2 (3C), 125.6, 127.1 (2C), 131.1 (2C), 131.2 (2C), 133.0, 159.1, 186.4; IR (KBr)/cm−1, 2970, 1666, 1512, 1319, 1234; HRMS (ESI): calcd for C19H14F3NO2 (MH+) 346.1055; found 346.1053.",1-(4-Methoxyphenyl)-2-(4-(trifluoromethyl)phenyl)-1H-pyrrole-3-carbaldehyde,O=CC1=C(C2=CC=C(C(F)(F)F)C=C2)N(C3=CC=C(OC)C=C3)C=C1,"1H NMR (400 MHz, CDCl3) δ 3.81 (s, 3H), 6.84 (d, J = 9.0 Hz, 2H), 6.89 (d, J = 3.1 Hz, 1H), 6.92 (d, J = 3.0 Hz, 1H), 7.02 (d, J = 8.9 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H), 9.70 (s, 1H)","13C NMR (75 MHz, CDCl3) δ 55.4, 108.3, 114.5 (2C), 124.9, 125.1, 125.2 (3C), 125.6, 127.1 (2C), 131.1 (2C), 131.2 (2C), 133.0, 159.1, 186.4","400 MHz, CDCl3","3.81 (s, 3H), 6.84 (d, J = 9.0 Hz, 2H), 6.89 (d, J = 3.1 Hz, 1H), 6.92 (d, J = 3.0 Hz, 1H), 7.02 (d, J = 8.9 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H), 9.70 (s, 1H)","75 MHz, CDCl3","55.4, 108.3, 114.5, 124.9, 125.1, 125.2, 125.6, 127.1, 131.1, 131.2, 133.0, 159.1, 186.4",35539447.0,RSC Adv.; 8(28):15448-15458,RSC Adv,N/A,CC BY,2022-05-10 23:28:03,no
PMC6269994,"3-(4-Chlorophenylselenyl)-1-methyl-1H-indole (3f): Yield: 0.170 g (53%). 1H-NMR (CDCl3, 200 MHz): δ = 7.59 (d, J = 7.7, 1H), 7.03–7.39 (m, 8H), 3.83 (s, 3H). 13C-NMR (50 MHz, CDCl3): δ = 137.5, 135.6, 132.5, 131.5, 130.4, 129.9, 128.9, 122.6, 120.5, 120.3, 109.6, 91.7, 33.0. MS: m/z (rel. int.) 321 (8.7), 241 (100.0), 130.0 (26.7), 77 (11.5).",3-(4-Chlorophenylselenyl)-1-methyl-1H-indole,CN1C=C([Se]C2=CC=C(Cl)C=C2)C3=C1C=CC=C3,"1H-NMR (CDCl3, 200 MHz): δ = 7.59 (d, J = 7.7, 1H), 7.03–7.39 (m, 8H), 3.83 (s, 3H)","13C-NMR (50 MHz, CDCl3): δ = 137.5, 135.6, 132.5, 131.5, 130.4, 129.9, 128.9, 122.6, 120.5, 120.3, 109.6, 91.7, 33.0","CDCl3, 200 MHz","7.59 (d, J = 7.7, 1H), 7.03–7.39 (m, 8H), 3.83 (s, 3H)","50 MHz, CDCl3","137.5, 135.6, 132.5, 131.5, 130.4, 129.9, 128.9, 122.6, 120.5, 120.3, 109.6, 91.7, 33.0",23563858.0,Molecules. 2013 Apr 5; 18(4):4081-4090,Molecules,2013.0,CC BY,2021-01-05 22:00:53,no
PMC6257647,"Synthesis of 7-(4-chlorobutoxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-chromen-4-one (7): 1-Bromo-4-chlorobutane (0.62 g, 3.59 mmol, 1.20 equiv) and potassium carbonate (0.413 g, 2.97 mmol, 1.00 equiv.) were added to a solution of 4 (1.39 g, 2.97 mmol, 1.00 equiv.) in DMF (20 mL) under nitrogen and stirred overnight at R.T. The reaction mixture was diluted in CH2Cl2 (100 mL) and washed with 3 M aq. HCl (3 × 100 mL). The organic layer was then dried over MgSO4 and filtered. The solvent was evaporated under reduced pressure. Without further purification, the crude product was added to a mixture of acetonitrile (60 mL) and 3 M aq. HCl (30 mL). The resulting solution was stirred and refluxed for 1 hour, and then ethyl acetate (100 mL) and water (100 mL) were added. The organic layer was washed with 3 M aq. HCl (3 × 100 mL), dried over MgSO4, and filtered. The solvent was evaporated under reduced pressure and the purification of the resulting residue by silica gel flash chromatography (eluent: 8:2 toluene/methanol) gave 7 as a bright yellow solid (0.71 g, 61% yield). 1H- NMR (250 MHz, DMSO-d6, 25 °C): δ = 1.80-2.01 (m, 4H, 2 × CH2), 3.66-3.80 (m, 2H, CH2), 4.00-4.22 (m, 2H, CH2), 6.34 (d, 4JH,H = 2.2 Hz, 1 H, 6-H), 6.70 (d, 4JH,H = 2.0 Hz, 1 H, 8-H), 6.89 (d, 3JH,H = 8.5 Hz, 1 H, 5’-H), 7.57 (dd, 3JH,H = 8.5 Hz, 4JH,H = 2.0 Hz, 1 H, 6’-H), 7.73 (d, 4JH,H = 2.0 Hz, 1 H, 2’-H) ppm; 13C-NMR (62.9 MHz, DMSO-d6, 25 °C): δ = 175.5, 163.7, 159.9, 155.6, 147.4, 146.8, 144.6, 135.6, 121.5, 119.6, 115.1, 114.8, 103.6, 97.4, 91.9, 67.3, 44.7, 28.3, 25.5 ppm; MS (ESI-MS): m/z 393, [M+H]+; Elemental analysis: calcd. for C19H17ClO7: C 58.10, H 4.36; found C 58.18, H 4.41.","7-(4-chlorobutoxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-chromen-4-one",O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=C1C(O)=CC(OCCCCCl)=C3,"1H- NMR (250 MHz, DMSO-d6, 25 °C): δ = 1.80-2.01 (m, 4H, 2 × CH2), 3.66-3.80 (m, 2H, CH2), 4.00-4.22 (m, 2H, CH2), 6.34 (d, 4JH,H = 2.2 Hz, 1 H, 6-H), 6.70 (d, 4JH,H = 2.0 Hz, 1 H, 8-H), 6.89 (d, 3JH,H = 8.5 Hz, 1 H, 5’-H), 7.57 (dd, 3JH,H = 8.5 Hz, 4JH,H = 2.0 Hz, 1 H, 6’-H), 7.73 (d, 4JH,H = 2.0 Hz, 1 H, 2’-H) ppm","13C-NMR (62.9 MHz, DMSO-d6, 25 °C): δ = 175.5, 163.7, 159.9, 155.6, 147.4, 146.8, 144.6, 135.6, 121.5, 119.6, 115.1, 114.8, 103.6, 97.4, 91.9, 67.3, 44.7, 28.3, 25.5 ppm","250 MHz, DMSO-d6, 25 °C","1.80-2.01 (m, 4H, 2 × CH2), 3.66-3.80 (m, 2H, CH2), 4.00-4.22 (m, 2H, CH2), 6.34 (d, 4JH,H = 2.2 Hz, 1 H, 6-H), 6.70 (d, 4JH,H = 2.0 Hz, 1 H, 8-H), 6.89 (d, 3JH,H = 8.5 Hz, 1 H, 5’-H), 7.57 (dd, 3JH,H = 8.5 Hz, 4JH,H = 2.0 Hz, 1 H, 6’-H), 7.73 (d, 4JH,H = 2.0 Hz, 1 H, 2’-H)","62.9 MHz, DMSO-d6, 25 °C","175.5, 163.7, 159.9, 155.6, 147.4, 146.8, 144.6, 135.6, 121.5, 119.6, 115.1, 114.8, 103.6, 97.4, 91.9, 67.3, 44.7, 28.3, 25.5",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC10057394,"5-bromo-2-[(3,4-dichlorobenzoyl)amino]benzoic Acid (2) Prepared following general method Section 3.1.1. Reaction time: 3 h. Yield = 69%. 1H-NMR (DMSO-d6): δ (ppm) 7.50 (dd, J = 8.8, J = 2.6 Hz, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.96 (dd, J = 8.5 Hz, J = 2.0 Hz, 1H), 8.13-8.14 (m, 2H), 8.57 (d, J = 8.8 Hz, 1H). 13C-NMR (DMSO-d6): δ (ppm) 114.4, 121.0, 127.7, 127.8, 129.6, 131.5, 132.2, 133.2, 134.1, 134.9, 136.1, 140.3, 162.3, 168.5. HRMS (TOF, ES-) m/z [M-H]−: Calculated for C14H7NO3Cl2Br 385.8986, found 385.8989.","5-bromo-2-[(3,4-dichlorobenzoyl)amino]benzoic Acid",O=C(O)C1=CC(Br)=CC=C1NC(C2=CC=C(Cl)C(Cl)=C2)=O,"1H-NMR (DMSO-d6): δ (ppm) 7.50 (dd, J = 8.8, J = 2.6 Hz, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.96 (dd, J = 8.5 Hz, J = 2.0 Hz, 1H), 8.13-8.14 (m, 2H), 8.57 (d, J = 8.8 Hz, 1H)","13C-NMR (DMSO-d6): δ (ppm) 114.4, 121.0, 127.7, 127.8, 129.6, 131.5, 132.2, 133.2, 134.1, 134.9, 136.1, 140.3, 162.3, 168.5",DMSO-d6,"7.50 (dd, J = 8.8, J = 2.6 Hz, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.96 (dd, J = 8.5 Hz, J = 2.0 Hz, 1H), 8.13-8.14 (m, 2H), 8.57 (d, J = 8.8 Hz, 1H)",DMSO-d6,"114.4, 121.0, 127.7, 127.8, 129.6, 131.5, 132.2, 133.2, 134.1, 134.9, 136.1, 140.3, 162.3, 168.5",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC10097314,"2,5-Bis(5-bromo-4-octylthiazol-2-yl)thiophene (Tz): 2,5-Bis(4-octylthiazol-2-yl)thiophene (2) (1 g, 2.1 mmol) and N-bromosuccinimide (NBS) (0.94 g, 5.3 mmol) were dissolved in dimethylformamide (DMF) (60 mL) and stirred at RT overnight. The reaction mixture was poured into water. The organic phase was extracted with dichloromethane and water and dried over anhydrous MgSO4. The solvent was then removed by evaporation under reduced pressure. The resulting product was recrystallized using MC and methanol to yield a pure yellow solid (1.1 g, 83%). 1H NMR (400 MHz, CDCl3), δ (ppm): 7.20 (s, 2H), 2.66 (t, J = 8.0 Hz, 2H), 1.65 (m, 2H), 1.25 (m, 10H), and 0.82 (t, J = 8.0 Hz, 3H). 13C NMR (100 MHz, CDCl3), δ (ppm): 159.88, 157.22, 138.74, 126.64, 103.81, 32.02, 29.85, 29.55, 29.50, 29.35, 28.85, 22.83, and 14.28.","2,5-Bis(5-bromo-4-octylthiazol-2-yl)thiophene",CCCCCCCCC1=C(Br)SC(C2=CC=C(C3=NC(CCCCCCCC)=C(Br)S3)S2)=N1,"1H NMR (400 MHz, CDCl3), δ (ppm): 7.20 (s, 2H), 2.66 (t, J = 8.0 Hz, 2H), 1.65 (m, 2H), 1.25 (m, 10H), and 0.82 (t, J = 8.0 Hz, 3H)","13C NMR (100 MHz, CDCl3), δ (ppm): 159.88, 157.22, 138.74, 126.64, 103.81, 32.02, 29.85, 29.55, 29.50, 29.35, 28.85, 22.83, and 14.28","400 MHz, CDCl3","7.20 (s, 2H), 2.66 (t, J = 8.0 Hz, 2H), 1.65 (m, 2H), 1.25 (m, 10H), 0.82 (t, J = 8.0 Hz, 3H)","100 MHz, CDCl3","159.88, 157.22, 138.74, 126.64, 103.81, 32.02, 29.85, 29.55, 29.50, 29.35, 28.85, 22.83, 14.28",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6257228,"4.4. Preparation of (2R,3S,4R)-N-Benzyl-2-phenylsulfonylmethyl-3,4-isopropylidenedioxypyrrolidine (9) Scheme 2, step e: LiAlH4 (7 mg, 0.19 mmol) was added to a solution of 11 (38 mg, 0.1 mmol) in dry THF (1 mL) at 0 °C. The resulting mixture was stirred for 1h, allowing to warm to rt, whereupon the reaction was quenched with wet ether, dried (Na2SO4), filtered, and concentrated. The resulting crude residue was purified by flash chromatography (silica gel, n-hexane/EtOAc 8:2) to yield benzyl derivative 9 (10 mg, 30%). IR (film) ν (cm−1) 2983, 2942, 1454, 1377, 1307, 1209, 1148, 1086, 1054; 1H-NMR (400 MHz) δ = 7.90–7.15 (m, 10H), 4.70 (m, 1H), 4.64 (m, 1H), 3.81 (d, J = 13.3 Hz, 1H), 3.55 (d, J = 13.3 Hz, 1H), 3.32–3.27 (m, 2H), 3.13 (dd, J = 13.5 and 9.0 Hz, 1H), 2.87 (dd, J = 10.7 and 5.3 Hz, 1H), 2.68 (d, J = 10.7 Hz, 1H), 1.50 (s, 3H),1.28 (s, 3H); 13C-NMR (100 MHz) δ = 139.4, 137.0, 133.7, 129.2, 128.3, 128.1, 127.1, 112.4, 84.3, 78.7, 63.4, 57.3, 56.6, 55.1, 27.0, 25.0; HRMS (ESI) C21H25NO4S requires (M+Na) 410.1402; found 410.1397; [α]D20 = + 20.2 (c 1.0, CHCl3).","(2R,3S,4R)-N-Benzyl-2-phenylsulfonylmethyl-3,4-isopropylidenedioxypyrrolidine",CC1(O[C@@]2([H])[C@H](CS(=O)(C3=CC=CC=C3)=O)N(CC4=CC=CC=C4)C[C@@]2([H])O1)C,"1H-NMR (400 MHz) δ = 7.90–7.15 (m, 10H), 4.70 (m, 1H), 4.64 (m, 1H), 3.81 (d, J = 13.3 Hz, 1H), 3.55 (d, J = 13.3 Hz, 1H), 3.32–3.27 (m, 2H), 3.13 (dd, J = 13.5 and 9.0 Hz, 1H), 2.87 (dd, J = 10.7 and 5.3 Hz, 1H), 2.68 (d, J = 10.7 Hz, 1H), 1.50 (s, 3H),1.28 (s, 3H)","13C-NMR (100 MHz) δ = 139.4, 137.0, 133.7, 129.2, 128.3, 128.1, 127.1, 112.4, 84.3, 78.7, 63.4, 57.3, 56.6, 55.1, 27.0, 25.0",400 MHz,"7.90–7.15 (m, 10H), 4.70 (m, 1H), 4.64 (m, 1H), 3.81 (d, J = 13.3 Hz, 1H), 3.55 (d, J = 13.3 Hz, 1H), 3.32–3.27 (m, 2H), 3.13 (dd, J = 13.5 and 9.0 Hz, 1H), 2.87 (dd, J = 10.7 and 5.3 Hz, 1H), 2.68 (d, J = 10.7 Hz, 1H), 1.50 (s, 3H),1.28 (s, 3H)",100 MHz,"139.4, 137.0, 133.7, 129.2, 128.3, 128.1, 127.1, 112.4, 84.3, 78.7, 63.4, 57.3, 56.6, 55.1, 27.0, 25.0",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC9027910,"N-(4-((4-fluorobenzyl)oxy)benzyl)-6-methoxy-2-methylquinolin-4-amine (9x): Flash column chromatography on silica gel (hexanes/ethyl acetate, 90/10 to 0/100), pale yellow solid, 28% yield, m.p. = 141–143 °C, HPLC: 97%; 1H NMR (400 MHz, DMSO-d6) δ ppm 2.36 (s, 3H), 3.89 (s, 3H), 4.49 (d, J = 5.8 Hz, 2H), 5.05 (s, 2H), 6.28 (s, 1H), 6.98 (d, J = 8.2 Hz, 2H), 7.18–7.26 (m, 3H), 7.33 (d, J = 8.1 Hz, 2H), 7.46–7.50 (m, 2H), 7.62–7.66 (m, 2H), 7.70 (t, J = 6.0 Hz, 1H); 13C NMR (101 MHz, DMSO) δ ppm: 25.11, 45.53, 56.12, 68.94, 99.32, 101.48, 115.23, 115.67 (d, J = 21,8 Hz, 2C), 118.35, 120.84, 128.70 (2C), 129.72, 130.34 (d, J = 9,09 Hz, 2C), 131.63, 133.83 (d, J = 3,03 Hz), 143.40, 149.92, 156.09, 157.70, 162.20 (d, J = 244.4 Hz).",N-(4-((4-fluorobenzyl)oxy)benzyl)-6-methoxy-2-methylquinolin-4-amine,CC1=NC2=CC=C(OC)C=C2C(NCC3=CC=C(OCC4=CC=C(F)C=C4)C=C3)=C1,"1H NMR (400 MHz, DMSO-d6) δ ppm 2.36 (s, 3H), 3.89 (s, 3H), 4.49 (d, J = 5.8 Hz, 2H), 5.05 (s, 2H), 6.28 (s, 1H), 6.98 (d, J = 8.2 Hz, 2H), 7.18–7.26 (m, 3H), 7.33 (d, J = 8.1 Hz, 2H), 7.46–7.50 (m, 2H), 7.62–7.66 (m, 2H), 7.70 (t, J = 6.0 Hz, 1H)","13C NMR (101 MHz, DMSO) δ ppm: 25.11, 45.53, 56.12, 68.94, 99.32, 101.48, 115.23, 115.67 (d, J = 21,8 Hz, 2C), 118.35, 120.84, 128.70 (2C), 129.72, 130.34 (d, J = 9,09 Hz, 2C), 131.63, 133.83 (d, J = 3,03 Hz), 143.40, 149.92, 156.09, 157.70, 162.20 (d, J = 244.4 Hz)","400 MHz, DMSO-d6","2.36 (s, 3H), 3.89 (s, 3H), 4.49 (d, J = 5.8 Hz, 2H), 5.05 (s, 2H), 6.28 (s, 1H), 6.98 (d, J = 8.2 Hz, 2H), 7.18–7.26 (m, 3H), 7.33 (d, J = 8.1 Hz, 2H), 7.46–7.50 (m, 2H), 7.62–7.66 (m, 2H), 7.70 (t, J = 6.0 Hz, 1H)","101 MHz, DMSO","25.11, 45.53, 56.12, 68.94, 99.32, 101.48, 115.23, 115.67, 118.35, 120.84, 128.70, 129.72, 130.34, 131.63, 133.83, 143.40, 149.92, 156.09, 157.70, 162.20",35458755.0,Molecules. 2022 Apr 15; 27(8):2556,Molecules,2022.0,CC BY,2022-04-23 23:29:07,no
PMC6017890,"2,2-Dimethyl-4-nitro-3-(3,4,5-trimethoxyphenyl)butanal (14ae). Colorless oil; IR (ATR): ν = 2972, 2939, 2835, 1722, 1589, 1552, 1460, 1242, 1124, 1005, 729 cm−1; 1H-NMR (CDCl3): δH = 9.52 (s, 1H), 6.38 (s, 2H), 4.85 (dd, J = 13.1, 11.3 Hz, 1H), 4.69 (dd, J = 13.1, 4.2 Hz, 1H), 3.85 (s, 6H), 3.83 (s, 3H), 3.70 (dd, J = 11.3, 4.2 Hz, 1H), 1.16 (s, 3H), 1.06 (s, 3H) ppm; 13C-NMR (CDCl3): δC = 204.3, 153.1, 137.7, 131.0, 106.2, 76.3, 60.7, 56.1, 48.9, 48.2, 21.7, 19.3 ppm; MS (EI, 70 eV): m/z (%) = 311 (M+, 16), 194 (100), 179 (35); HR-MS (EI): m/z calcd. for C15H21NO6 [M]+: 311.1369, found: 311.1367; HPLC: Chiralpak OD-H, λ = 210 nm, n-hexane/2-propanol, 80:20, 1.0 mL/min, tr (R) = 18.2 min, tr (S) = 20.7 min.","2,2-Dimethyl-4-nitro-3-(3,4,5-trimethoxyphenyl)butanal",O=CC(C)(C)C(C1=CC(OC)=C(OC)C(OC)=C1)C[N+]([O-])=O,"1H-NMR (CDCl3): δH = 9.52 (s, 1H), 6.38 (s, 2H), 4.85 (dd, J = 13.1, 11.3 Hz, 1H), 4.69 (dd, J = 13.1, 4.2 Hz, 1H), 3.85 (s, 6H), 3.83 (s, 3H), 3.70 (dd, J = 11.3, 4.2 Hz, 1H), 1.16 (s, 3H), 1.06 (s, 3H) ppm","13C-NMR (CDCl3): δC = 204.3, 153.1, 137.7, 131.0, 106.2, 76.3, 60.7, 56.1, 48.9, 48.2, 21.7, 19.3 ppm",CDCl3,"9.52 (s, 1H), 6.38 (s, 2H), 4.85 (dd, J = 13.1, 11.3 Hz, 1H), 4.69 (dd, J = 13.1, 4.2 Hz, 1H), 3.85 (s, 6H), 3.83 (s, 3H), 3.70 (dd, J = 11.3, 4.2 Hz, 1H), 1.16 (s, 3H), 1.06 (s, 3H)",CDCl3,"204.3, 153.1, 137.7, 131.0, 106.2, 76.3, 60.7, 56.1, 48.9, 48.2, 21.7, 19.3",29324713.0,Molecules. 2018 Jan 11; 23(1):141,Molecules,2018.0,CC BY,2021-01-05 19:30:01,no
PMC7187479,"Wiley‐VCH Verlag GmbH & Co. KGaATo provide the mechanistic insight into the cascade annulation, a typical reaction under condition A was then carried out but quenched at 0 °C before heating. Consequently, donor 5 and its dienol tautomer 5 a (1:9), as determined by 1H NMR of the crude mixture,15 was completely recovered, suggesting that deprotonation did occur but the Michael–Dieckmann sequence was not activated. Additionally, no 1,4‐conjugate addition intermediates had been identified for many other vinylogous donors that we used to generate adducts 15–17, 23–26, 32, and 34 (Table 2), wherein all reactions were conducted and completed at lower temperature (0–50 °C). Taken together, these results imply that Michael addition is very likely to be a rate‐limiting step in the above domino reactions; once it is initiated, the ensuing Dieckmann condensation might take place spontaneously. Structurally, though vinylogous donors potentially suffer self‐condensation through their cross‐conjugated dienolates after deprotonation,1c, 16 however, no self‐condensation products have been detected in all cases (35 examples) examined under reaction condition A, B, and C in Table 2. According to retrosynthetic analysis shown in pathway A (Scheme 1), fragments 1 and 2 are apparently two feasible chemical elements to implement the Michael‐type [4+2] anionic annulation which had been experimentally realized in many cases as shown in Table 2. Encouraged by these results, we decided to carry out the total synthesis of (±)‐ABX based on the original design (Scheme 4). Starting with bis‐benzyl protected tetralone 48, enone ester 50 was readily prepared in 57 % over 4 steps through a similar synthetic sequence for enone ester 5 as depicted in Scheme 2. Vinylogous donor 50 was then treated with aldehyde 2 under standard conditions to afford tricyclic aldehyde 53 in 53 % yield. Aldehyde 2 was readily prepared in 78 % yield through a Wittig reaction in the presence of ylide 51 and 2‐butynal, formed in situ by oxidation of 2‐butynol with MnO2. A series of cascade events, involving metal‐catalyzed cycloisomerization, proton demetallation, Friedel–Crafts acylation, and ring closure, was then successfully triggered between compound 53 and orcinol under catalysis with PtCl2 to give the corresponding intermediates 55 and 56 (1:1 as determined by 1H NMR), which contained requisite D, E, and F rings by putatively invoking the intermediacy of the metal‐benzopyrilium 54 species as an initiator.17 Without purification, the mixture was further deprotected through hydrogenolysis under catalysis with Pd/C to accomplish the desired target, in racemic form, in 65 % yield over 2 steps. The 1H NMR, 13C NMR, and mass spectral data obtained for the synthetic (±)‐ABX, whose structure is further unambiguously confirmed by an X‐ray crystallographic analysis,18 are in good agreement with those reported for the naturally occurring product.11c, 11d, 19   Scheme 4 Application to the total synthesis of (±)‐ABX.",(±)‐ABX,N/A,"The 1H NMR, 13C NMR, and mass spectral data obtained for the synthetic (±)‐ABX","The 1H NMR, 13C NMR, and mass spectral data obtained for the synthetic (±)‐ABX",N/A,N/A,N/A,N/A,31944523.0,Angew Chem Int Ed Engl. 2020 Apr 16; 59(16):6540-6545,Angew Chem Int Ed Engl,2020.0,CC BY,2021-01-06 08:08:04,no
PMC10055744,"3.3.1. Ethyl 2,3,5,6-Tetrafluoro-4-[2-{4-(7,7,8,8,9,9,10,10,10-nonafluorodecyloxy)phenyl}ethyn-1-yl]benzoate (2a) Yield: 56% (white solid), m.p. = 71 °C determined by DSC; 1H-NMR (CDCl3): δ 1.41 (t, J = 6.8 Hz, 3H), 1.46–1.53 (m, 4H), 1.66 (quin, J = 7.6 Hz, 2H), 1.83 (quin, J = 7.6 Hz, 2H), 2.00–2.16 (m, 2H), 4.00 (t, J = 6.4 Hz, 2H), 4.45 (q, J = 7.2 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H); 13C-NMR (CDCl3): δ 13.9, 20.0 (t, J = 2.9 Hz), 25.7, 28.8, 28.9, 30.7 (t, J = 22.7 Hz), 62.7, 67.8, 72.9 (t, J = 3.7 Hz), 104.4 (t, J = 3.6 Hz), 105–120 (m, 4C for C4F9 moiety), 107.9 (t, J = 17.6 Hz), 112.0 (t, J = 16.1 Hz), 113.1, 114.6, 133.7, 144.5 (ddt, J = 255.2, 14.7, 5.1 Hz), 146.5 (ddt, J = 253.8, 13.9, 3.7 Hz), 159.3, 160.5; 19F-NMR (CDCl3, C6F6): δ −82.3 (t, J = 9.9 Hz, 3F), −115.82 to −116.03 (m, 2F), −125.70 to −125.88 (m, 2F), −127.28 to −127.46 (m, 2F), −137.44 to −137.59 (m, 2F), −141.45 to −141.62 (m, 2F); IR (KBr) ν 2948, 2223, 1730, 1476, 1334, 1205, 1132, 984, 837 cm−1; HRMS (FAB) Calcd for (M+) C27H21F13O3: 640.1283, observed: 640.1275.","Ethyl 2,3,5,6-Tetrafluoro-4-[2-{4-(7,7,8,8,9,9,10,10,10-nonafluorodecyloxy)phenyl}ethyn-1-yl]benzoate",O=C(OCC)C1=C(F)C(F)=C(C#CC2=CC=C(OCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C=C2)C(F)=C1F,"1H-NMR (CDCl3): δ 1.41 (t, J = 6.8 Hz, 3H), 1.46–1.53 (m, 4H), 1.66 (quin, J = 7.6 Hz, 2H), 1.83 (quin, J = 7.6 Hz, 2H), 2.00–2.16 (m, 2H), 4.00 (t, J = 6.4 Hz, 2H), 4.45 (q, J = 7.2 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H)","13C-NMR (CDCl3): δ 13.9, 20.0 (t, J = 2.9 Hz), 25.7, 28.8, 28.9, 30.7 (t, J = 22.7 Hz), 62.7, 67.8, 72.9 (t, J = 3.7 Hz), 104.4 (t, J = 3.6 Hz), 105–120 (m, 4C for C4F9 moiety), 107.9 (t, J = 17.6 Hz), 112.0 (t, J = 16.1 Hz), 113.1, 114.6, 133.7, 144.5 (ddt, J = 255.2, 14.7, 5.1 Hz), 146.5 (ddt, J = 253.8, 13.9, 3.7 Hz), 159.3, 160.5",CDCl3,"1.41 (t, J = 6.8 Hz, 3H), 1.46–1.53 (m, 4H), 1.66 (quin, J = 7.6 Hz, 2H), 1.83 (quin, J = 7.6 Hz, 2H), 2.00–2.16 (m, 2H), 4.00 (t, J = 6.4 Hz, 2H), 4.45 (q, J = 7.2 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H)",CDCl3,"13.9, 20.0, 25.7, 28.8, 28.9, 30.7, 62.7, 67.8, 72.9, 104.4, 105–120, 107.9, 112.0, 113.1, 114.6, 133.7, 144.5, 146.5, 159.3, 160.5",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6268315,"N-(3-Trifluoromethylphenyl)quinoline-2-carboxamide (18b). Yield 31%; Mp. 121–122 °C; IR (Zn/Se ATR, cm−1): 3,339w, 1,692s, 1,614w, 1,536m, 1,490m, 1,424w, 1,330s, 1,223w, 1,166m, 1,109s, 1,091s, 1,065m, 952w, 933w, 874s, 844m, 808s, 771s, 744w, 698s; 1H-NMR (DMSO-d6), δ: 11.08 (bs, 1H), 8.59 (d, J = 8.5 Hz, 1H), 8.46 (s, 1H), 8.17–8.31 (m, 3H), 8.08 (d, J = 8.0 Hz, 1H), 7.89 (t, J = 7.4 Hz, 1H), 7.68–7.78 (m, 1H), 7.61 (t, J = 8.0 Hz, 1H), 7.46 (d, J = 7.5 Hz, 1H); 13C-NMR (DMSO-d6), δ: 163.26, 149.64, 145.90, 139.23, 138.21, 130.69, 129.86, 129.35 (q, 2JFC = 32 Hz), 129.34, 129.03, 128.45, 128.16, 124.20 (q, 1JFC = 273 Hz), 123.91, 120.24 (q, 3JFC = 3.7 Hz), 118.78, 116.61 (q, 3JFC = 3.7 Hz); HR-MS: for C17H12F3N2O [M+H]+ calculated 317.0896 m/z, found 317.0892 m/z.",N-(3-Trifluoromethylphenyl)quinoline-2-carboxamide,O=C(C1=NC2=CC=CC=C2C=C1)NC3=CC=CC(C(F)(F)F)=C3,"1H-NMR (DMSO-d6), δ: 11.08 (bs, 1H), 8.59 (d, J = 8.5 Hz, 1H), 8.46 (s, 1H), 8.17–8.31 (m, 3H), 8.08 (d, J = 8.0 Hz, 1H), 7.89 (t, J = 7.4 Hz, 1 H), 7.68–7.78 (m, 1 H), 7.61 (t, J = 8.0 Hz, 1 H), 7.46 (d, J = 7.5 Hz, 1H)","13C-NMR (DMSO-d6), δ: 163.26, 149.64, 145.90, 139.23, 138.21, 130.69, 129.86, 129.35 (q, 2JFC = 32 Hz), 129.34, 129.03, 128.45, 128.16, 124.20 (q, 1JFC = 273 Hz), 123.91, 120.24 (q, 3JFC = 3.7 Hz), 118.78, 116.61 (q, 3JFC = 3.7 Hz)",DMSO-d6,"11.08 (bs, 1H), 8.59 (d, J = 8.5 Hz, 1H), 8.46 (s, 1H), 8.17–8.31 (m, 3H), 8.08 (d, J = 8.0 Hz, 1H), 7.89 (t, J = 7.4 Hz, 1 H), 7.68–7.78 (m, 1 H), 7.61 (t, J = 8.0 Hz, 1 H), 7.46 (d, J = 7.5 Hz, 1H)",DMSO-d6,"163.26, 149.64, 145.90, 139.23, 138.21, 130.69, 129.86, 129.35, 129.34, 129.03, 128.45, 128.16, 124.20, 123.91, 120.24, 118.78, 116.61",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC8838460,"2-(Oxiran-2-ylmethylthio)-1H-benzo[d]imidazole (4g) Yield (method A: 55%, B: 50%, C: 48%), yellow crystals, mp 211 °C; TLC, Rf 0.22 (4:6 EtOAc-n-hexane); 1H NMR (DMSO-d6, 300 MHz): δ 2.48–3.41 (m, 2H, CH2), 4.02–4.46 (m, 1H, CH), 5.70 (d, 2H, J = 3.9 Hz, SCH2), 7.11–7.14 (m, 2H, ArH), 7.39–7.44 (m, 2H, ArH); 13C NMR (DMSO-d6, 75 MHz): δ 31.3 (SCH2), 48.2(CH2), 60.6 (CH), 108.6 (C-7), 116.9 (C-4), 120.7 (C-5), 121.7 (C-6), 135.8 (C-8), 142.8 (C-9), 146.2 (C-S); EIMS: m/z (%) = 206 (100), 162 (78),148 (13), 118 (99), 77 (8); HREIMS (M+): Calcd for C10H10N2OS: m/z 206.0514. Found: 206.0527.",2-(Oxiran-2-ylmethylthio)-1H-benzo[d]imidazole,C1(SCC2OC2)=NC3=CC=CC=C3N1,"1H NMR (DMSO-d6, 300 MHz): δ 2.48–3.41 (m, 2H, CH2), 4.02–4.46 (m, 1H, CH), 5.70 (d, 2H, J = 3.9 Hz, SCH2), 7.11–7.14 (m, 2H, ArH), 7.39–7.44 (m, 2H, ArH)","13C NMR (DMSO-d6, 75 MHz): δ 31.3 (SCH2), 48.2(CH2), 60.6 (CH), 108.6 (C-7), 116.9 (C-4), 120.7 (C-5), 121.7 (C-6), 135.8 (C-8), 142.8 (C-9), 146.2 (C-S)","DMSO-d6, 300 MHz","2.48–3.41 (m, 2H, CH2), 4.02–4.46 (m, 1H, CH), 5.70 (d, 2H, J = 3.9 Hz, SCH2), 7.11–7.14 (m, 2H, ArH), 7.39–7.44 (m, 2H, ArH)","DMSO-d6, 75 MHz","31.3, 48.2, 60.6, 108.6, 116.9, 120.7, 121.7, 135.8, 142.8, 146.2",35164122.0,Molecules. 2022 Jan 27; 27(3):865,Molecules,2022.0,CC BY,2022-02-16 23:19:11,no
PMC6270175,"(2E,4E)-Dimethyl-2-(dipropylamino)hexa-2,4-dienedioate (2E,4E-4k). Rf = 0.44 (4:1 hexanes/ethyl acetate), Yellow sticky liquid; 1H-NMR (CDCl3) δ 0.87 (t, J = 7.5 Hz, 6H), 1.51–1.64 (m, 4H), 3.02 (t, J = 7.5 Hz, 4H), 3.67 (s, 3H), 3.89 (s, 3H), 5.15 (d, J = 12.0 Hz, 1H), 5.40 (d, J = 14.7 Hz, 1H), 7.21 (dd, J = 12.0, 14.7 Hz, 1H); 13C-NMR (CDCl3) δ 11.4, 20.9, 51.1, 52.7, 52.9, 97.4, 111.1, 143.1, 149.3, 166.1, 168.7; FT-IR (KBr) (cm–1) 1458, 1522, 1725, 2857, 2926, 2956; HRMS (EI+), calcd for C14H23NO4 (M+) 269.1627 found 269.1628.","(2E,4E)-Dimethyl-2-(dipropylamino)hexa-2,4-dienedioate",O=C(OC)/C(N(CCC)CCC)=C\C=C\C(OC)=O,"1H-NMR (CDCl3) δ 0.87 (t, J = 7.5 Hz, 6H), 1.51–1.64 (m, 4H), 3.02 (t, J = 7.5 Hz, 4H), 3.67 (s, 3H), 3.89 (s, 3H), 5.15 (d, J = 12.0 Hz, 1H), 5.40 (d, J = 14.7 Hz, 1H), 7.21 (dd, J = 12.0, 14.7 Hz, 1H)","13C-NMR (CDCl3) δ 11.4, 20.9, 51.1, 52.7, 52.9, 97.4, 111.1, 143.1, 149.3, 166.1, 168.7",CDCl3,"0.87 (t, J = 7.5 Hz, 6H), 1.51–1.64 (m, 4H), 3.02 (t, J = 7.5 Hz, 4H), 3.67 (s, 3H), 3.89 (s, 3H), 5.15 (d, J = 12.0 Hz, 1H), 5.40 (d, J = 14.7 Hz, 1H), 7.21 (dd, J = 12.0, 14.7 Hz, 1H)",CDCl3,"11.4, 20.9, 51.1, 52.7, 52.9, 97.4, 111.1, 143.1, 149.3, 166.1, 168.7",23446918.0,Molecules. 2013 Feb 27; 18(3):2611-2622,Molecules,2013.0,CC BY,2021-01-05 22:01:14,no
PMC10041534,"3-{3-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]-1H-indol-1-yl}propan-1-amine (11) A solution of 10 (170 mg, 0.40 mmol, 1 equiv) in anhydrous THF (10 mL) was added with a solution of 2 M BH3·DMS (1 mL, 2.0 mmol, 5 equiv) while being kept under a stream of N2 and cooled in an ice bath. After the addition, the mixture was refluxed for 3 h. After the mixture had cooled, MeOH (10 mL) and 3 N HCl were added, and the mixture was refluxed for 1 h. Then, the mixture was basified with 3 N NaOH, and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The collected organic layers were dried (Na2SO4) and evaporated under reduced pressure to afford a crude oil as a dense yellow oil that was purified by column chromatography (1:10) with CH2Cl2/MeOH (from 98:2 to 80:20) as the eluent to afford the title compound as a pale-yellow oil (112 mg, 67% yield). GC-MS m/z: 417 (M+, 6.8), 202 (100). LC-MS (ESI+) m/z: 418 [M + H]+, 440 [M + Na]+, 456 [M + K]+ LC-MS-MS 418: 418 (15.57), 186 (100). LC-MS-MS 440: 440 (100), 186 (9.69). HRMS (ESI+) calcd for C27H36N3O [M + H]+, 418.2853; found, 418.2714. 1H NMR (500 MHz, CDCl3): δ 1.52–1.86 (m, 8H), 1.87–2.08 (m, 4H), 2.33–2.53 (m, 4H), 2.68 (t, 2H, J = 6.8 Hz), 2.80 (t, 2H, J = 7.4 Hz), 2.88 (d, 2H, J = 5.9 Hz), 4.14 (t, 2H, J = 6.8 Hz), 5.07 (s, 2H), 6.89 (s, 1H), 7.03–7.12 (m, 1H), 7.12–7.22 (m, 3H), 7.22–7.29 (m, 2H), 7.32 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 7.7 Hz). 13C NMR (75 MHz, CDCl3): δ 25.01, 28.33, 31.17, 33.28, 35.95, 41.01, 46.05, 50.05, 58.55, 71.33, 82.40, 109.26, 114.85, 116.98, 118.43, 121.01, 121.05, 121.27, 125.05, 127.45, 127.72, 127.92, 136.35, 138.80, 143.38.","3-{3-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]-1H-indol-1-yl}propan-1-amine",N/A,"1H NMR (500 MHz, CDCl3): δ 1.52–1.86 (m, 8H), 1.87–2.08 (m, 4H), 2.33–2.53 (m, 4H), 2.68 (t, 2H, J = 6.8 Hz), 2.80 (t, 2H, J = 7.4 Hz), 2.88 (d, 2H, J = 5.9 Hz), 4.14 (t, 2H, J = 6.8 Hz), 5.07 (s, 2H), 6.89 (s, 1H), 7.03–7.12 (m, 1H), 7.12–7.22 (m, 3H), 7.22–7.29 (m, 2H), 7.32 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 7.7 Hz)","13C NMR (75 MHz, CDCl3): δ 25.01, 28.33, 31.17, 33.28, 35.95, 41.01, 46.05, 50.05, 58.55, 71.33, 82.40, 109.26, 114.85, 116.98, 118.43, 121.01, 121.05, 121.27, 125.05, 127.45, 127.72, 127.92, 136.35, 138.80, 143.38","500 MHz, CDCl3","1.52–1.86 (m, 8H), 1.87–2.08 (m, 4H), 2.33–2.53 (m, 4H), 2.68 (t, 2H, J = 6.8 Hz), 2.80 (t, 2H, J = 7.4 Hz), 2.88 (d, 2H, J = 5.9 Hz), 4.14 (t, 2H, J = 6.8 Hz), 5.07 (s, 2H), 6.89 (s, 1H), 7.03–7.12 (m, 1H), 7.12–7.22 (m, 3H), 7.22–7.29 (m, 2H), 7.32 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 7.7 Hz)","75 MHz, CDCl3","25.01, 28.33, 31.17, 33.28, 35.95, 41.01, 46.05, 50.05, 58.55, 71.33, 82.40, 109.26, 114.85, 116.98, 118.43, 121.01, 121.05, 121.27, 125.05, 127.45, 127.72, 127.92, 136.35, 138.80, 143.38",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6272141,"3.8. Synthesis of (9-Iodo-1,7-dicarba-closo-dodecarborane-1-yl)-ethyl carboxylate (9)Prepared according to the procedure described for compound 5; yield after purification: 78%. 1H-NMR (500 MHz, CDCl3): 4.22 (2H, q, CH2CH3), 3.15 (1H, s, cage C-H), 3.70–1.70 (10H, m, B10H10), 1.30 (3H, t, CH3CH2); 13C-NMR (126 MHz, CDCl3): 160.72, 73.65, 64.19, 55.64, 13.77. 11B-NMR (160 MHz, CDCl3): −3.84 (d, 1B), −5.91 (d, 1B), −8.55 (d, 1B), −10.12 (d, 1B), −11.15 (d, 1B), −11.99 (d, 1B), −13.12 (d, 1B), −15.59 (d, 1B), −17.58 (d, 1B), −23.76 (s, 1B).","(9-Iodo-1,7-dicarba-closo-dodecarborane-1-yl)-ethyl carboxylate",N/A,"1H-NMR (500 MHz, CDCl3): 4.22 (2H, q, CH2CH3), 3.15 (1H, s, cage C-H), 3.70–1.70 (10H, m, B10H10), 1.30 (3H, t, CH3CH2)","13C-NMR (126 MHz, CDCl3): 160.72, 73.65, 64.19, 55.64, 13.77","500 MHz, CDCl3","4.22 (2H, q, CH2CH3), 3.15 (1H, s, cage C-H), 3.70–1.70 (10H, m, B10H10), 1.30 (3H, t, CH3CH2)","126 MHz, CDCl3","160.72, 73.65, 64.19, 55.64, 13.77",25915463.0,Molecules. 2015 Apr 23; 20(5):7495-7508,Molecules,2015.0,CC BY,2021-01-05 22:02:35,no
PMC10009749,"5-Aminosalicylic acid methyl ester (0.42 g, 2.5 mmol) in DCM (2.5 mL) was added to succinic anhydride (0.23 g, 2.25 mmol) in DCM (2.5 mL). The reaction mixture was irradiated at 100 °C for 10 min and the resulting solid was filtered and recrystallized in MeOH to give the title compound as a pale-brown solid (0.57 g, 2.13 mmol, 94%). 1H NMR (400 MHz, DMSO-d6) δ 12.10 (s, 1H), 10.24 (s, 1H), 9.94 (s, 1H), 8.15 (d, J = 2.7 Hz, 1H), 7.61 (dd, J = 9.0, 2.7 Hz, 1H), 6.93 (d, J = 8.9 Hz, 1H), 3.89 (s, 3H), 2.52–2.48 (m, 4H); 13C NMR (101 MHz, DMSO-d6) δ 173.77, 169.80, 169.06, 155.76, 131.26, 127.10, 119.79, 117.48, 112.31, 52.44, 30.82, 28.78. m/z (ES−): 266.0 (M – H)− (100%). HRMS (ES+) for C12H14NO6 (M + H)+: calcd 268.0816, found 268.0817; purity as measured by 1H and 13C NMR was >99%.",N/A,N/A,"1H NMR (400 MHz, DMSO-d6) δ 12.10 (s, 1H), 10.24 (s, 1H), 9.94 (s, 1H), 8.15 (d, J = 2.7 Hz, 1H), 7.61 (dd, J = 9.0, 2.7 Hz, 1H), 6.93 (d, J = 8.9 Hz, 1H), 3.89 (s, 3H), 2.52–2.48 (m, 4H)","13C NMR (101 MHz, DMSO-d6) δ 173.77, 169.80, 169.06, 155.76, 131.26, 127.10, 119.79, 117.48, 112.31, 52.44, 30.82, 28.78","400 MHz, DMSO-d6","12.10 (s, 1H), 10.24 (s, 1H), 9.94 (s, 1H), 8.15 (d, J = 2.7 Hz, 1H), 7.61 (dd, J = 9.0, 2.7 Hz, 1H), 6.93 (d, J = 8.9 Hz, 1H), 3.89 (s, 3H), 2.52–2.48 (m, 4H)","101 MHz, DMSO-d6","173.77, 169.80, 169.06, 155.76, 131.26, 127.10, 119.79, 117.48, 112.31, 52.44, 30.82, 28.78",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC9519884,"About 10 mL of 30% H2O2 was added into a 100 ml flask and cooled by an ice-salt bath, 10 mL of 60% H2SO4 was added dropwise while maintaining the temperature <0 °C. Then 3, 5-diamino-N', 4-dinitro-1H-pyrazole-1-carboximidamide (1, 1.15 g, 5 mmol) was added to the mixed solution at 0 °C in batches after the addition was completed. The reaction temperature gradually rose to room temperature and reacted for another 3 h. After the reaction was completed, which was monitored by TLC (Solvent combination: EA:PE = 1:2; Rf = 0.40), the reaction solution was poured into ice water, and a yellow solid is precipitated. The precipitate was collected by filtration and washed with water to give 2 (0.58 g, 34.6%). Td (onset) 204 °C. 1H NMR (400 MHz, DMSO-d6) δ 9.88 (s, 1H), 8.82 (s, 1H). 13C NMR (101 MHz, DMSO-d6) δ 155.1, 150.2, 148.5, 109.0 ppm. IR (KBr) ν̃ =3439, 3374, 3304, 3248, 1655, 1565, 1530, 1504, 1451, 1434, 1377, 1346, 1313, 1255, 1214, 1172, 1085, 1034, 948, 879, 820, 783, 773, 762, 756, 715, 683, 674, 624, 517, 462 cm−1. Elemental analysis (%) for C4H4N8O6 (260.03) Calcd: C 18.47, H 1.55, N 43.08. Found: C 18.16, H 1.89, N 42.71.",2,N/A,"1H NMR (400 MHz, DMSO-d6) δ 9.88 (s, 1H), 8.82 (s, 1H)","13C NMR (101 MHz, DMSO-d6) δ 155.1, 150.2, 148.5, 109.0 ppm","400 MHz, DMSO-d6","9.88 (s, 1H), 8.82 (s, 1H)","101 MHz, DMSO-d6","155.1, 150.2, 148.5, 109.0",36171224.0,Nat Commun. 2022 Sep 28; 13:5697,Nat Commun,2022.0,CC BY,2022-10-02 23:16:31,no
PMC6271978,"5-(4-(2,3-Dihydro-1H-perimidin-2-yl)benzamido)pentanoic acid (18). Yield = 47%, mp 102.8–107.4 °C; 1H-NMR (DMSO-d6) δ: 1.55 (m, 4H), 2.22–2.28 (m, 2H), 3.25 (m, 2H), 5.42 (s, 1H), 6.50 (d, J = 7.2 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 7.15 (dd, J = 7.6 Hz, 8.0 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 7.87 (d, J = 8.0 Hz, 2H), 8.49 (t, J = 5.2 Hz, 1H); 13C-NMR (DMSO-d6) δ: 22.0, 28.6, 33.3, 38.8, 65.8, 104.7, 112.6, 115.6, 126.8, 127.0, 127.7, 134.3, 134.7, 142.4, 144.4, 165.7, 174.4; MS (ESI): m/z calcd. for C23H24N3O3 [M+H]+ 390.2, found: 390.1.","5-(4-(2,3-Dihydro-1H-perimidin-2-yl)benzamido)pentanoic acid",O=C(O)CCCCNC(C1=CC=C(C(N2)NC3=CC=CC4=CC=CC2=C34)C=C1)=O,"1H-NMR (DMSO-d6) δ: 1.55 (m, 4H), 2.22–2.28 (m, 2H), 3.25 (m, 2H), 5.42 (s, 1H), 6.50 (d, J = 7.2 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 7.15 (dd, J = 7.6 Hz, 8.0 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 7.87 (d, J = 8.0 Hz, 2H), 8.49 (t, J = 5.2 Hz, 1H)","13C-NMR (DMSO-d6) δ: 22.0, 28.6, 33.3, 38.8, 65.8, 104.7, 112.6, 115.6, 126.8, 127.0, 127.7, 134.3, 134.7, 142.4, 144.4, 165.7, 174.4",DMSO-d6,"1.55 (m, 4H), 2.22–2.28 (m, 2H), 3.25 (m, 2H), 5.42 (s, 1H), 6.50 (d, J = 7.2 Hz, 2H), 6.98 (d, J = 8.0 Hz, 2H), 7.15 (dd, J = 7.6 Hz, 8.0 Hz, 2H), 7.65 (d, J = 8.0 Hz, 2H), 7.87 (d, J = 8.0 Hz, 2H), 8.49 (t, J = 5.2 Hz, 1H)",DMSO-d6,"22.0, 28.6, 33.3, 38.8, 65.8, 104.7, 112.6, 115.6, 126.8, 127.0, 127.7, 134.3, 134.7, 142.4, 144.4, 165.7, 174.4",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC10059083,"N-(Benzyloxy)-2-chloroacetamide (398 mg, 2 mmol) and 4,4′-diselanediyldianiline (342 mg, 1 mmol) were dissolved in ethanol (40 mL) at room temperature, then sodium borohydride (250 mg, 6.60 mmol) was gradually added. TLC followed the reaction progress. After completion, 35 mL of water was added. Then, the product was extracted by DCM (2 × 20 mL) and dried with MgSO4. The product was isolated as a brown solid, which yielded 327 mg (97%); Rf = 0.53 [DCM: MeOH (95:5)]; MP: 100 °C. I.R. (KBr) λmax. cm−1: 3452, 3343, 3208, 1648, 1590; 1H NMR (400 MHz, DMSO) δ 11.07 (s, 1H, NH), 7.40–7.33 (m, 5H, Ar-H), 7.24 (d, J = 7.7 Hz, 2H, Ar-H), 6.52 (d, J = 7.7 Hz, 2H, Ar-H), 5.45 (s, 2H, NH2), 4.71 (s, 2H, CH2O), 3.21 (s, 2H, CH2Se); 13C NMR (101 MHz, DMSO) δ 166.60, 148.72, 135.90, 135.83, 128.80, 128.29, 128.22, 114.63, 112.59, 76.78, 27.88; M.S. (E.I., 70 ev) m/z (%) = 336.20 (M+, 10.01), 172 (6.38), 106.15 (16.69), 91 (100.0, base peak), 80.10 (9.92), 77.10 (9.26), 59.05 (0.40) 57.05 (0.81).",N/A,N/A,"1H NMR (400 MHz, DMSO) δ 11.07 (s, 1H, NH), 7.40–7.33 (m, 5H, Ar-H), 7.24 (d, J = 7.7 Hz, 2H, Ar-H), 6.52 (d, J = 7.7 Hz, 2H, Ar-H), 5.45 (s, 2H, NH2), 4.71 (s, 2H, CH2O), 3.21 (s, 2H, CH2Se)","13C NMR (101 MHz, DMSO) δ 166.60, 148.72, 135.90, 135.83, 128.80, 128.29, 128.22, 114.63, 112.59, 76.78, 27.88","400 MHz, DMSO","11.07 (s, 1H, NH), 7.40–7.33 (m, 5H, Ar-H), 7.24 (d, J = 7.7 Hz, 2H, Ar-H), 6.52 (d, J = 7.7 Hz, 2H, Ar-H), 5.45 (s, 2H, NH2), 4.71 (s, 2H, CH2O), 3.21 (s, 2H, CH2Se)","101 MHz, DMSO","166.60, 148.72, 135.90, 135.83, 128.80, 128.29, 128.22, 114.63, 112.59, 76.78, 27.88",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6273348,"(2-(2-Hydroxyphenyl)-4,5-dihydrooxazol-4-yl)methyl butyrate (5c) Yield: 82%; yellow oil; ESI-MS m/z 264.09 [M + H]+; 1H-NMR (500 MHz, CDCl3) δ 11.88 (s, 1H, Ar-OH), 7.66 (dd, J = 2.0, 8.0 Hz, 1H), 7.40 (m, 1H), 7.02 (dd, J = 1.0, 8.5 Hz, 1H), 6.89 (m, 1H), 4.65 (m, 1H), 4.50 (dd, J = 9.0, 10.0 Hz, 1H), 4.31 (m, 2H), 4.24 (dd, J = 4.5, 9.5 Hz, 1H), 2.29 (t, J = 7.0 Hz, 2H), 1.66 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 173.47, 166.71, 159.96, 133.74, 128.17, 118.73, 116.87, 110.32, 69.13, 65.25, 64.27, 36.13, 18.45, 13.60.","(2-(2-Hydroxyphenyl)-4,5-dihydrooxazol-4-yl)methyl butyrate",CCCC(OCC1N=C(C2=CC=CC=C2O)OC1)=O,"1H-NMR (500 MHz, CDCl3) δ 11.88 (s, 1H, Ar-OH), 7.66 (dd, J = 2.0, 8.0 Hz, 1H), 7.40 (m, 1H), 7.02 (dd, J = 1.0, 8.5 Hz, 1H), 6.89 (m, 1H), 4.65 (m, 1H), 4.50 (dd, J = 9.0, 10.0 Hz, 1H), 4.31 (m, 2H), 4.24 (dd, J = 4.5, 9.5 Hz, 1H), 2.29 (t, J = 7.0 Hz, 2H), 1.66 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H)","13C-NMR (125 MHz, CDCl3) δ 173.47, 166.71, 159.96, 133.74, 128.17, 118.73, 116.87, 110.32, 69.13, 65.25, 64.27, 36.13, 18.45, 13.60","500 MHz, CDCl3","11.88 (s, 1H, Ar-OH), 7.66 (dd, J = 2.0, 8.0 Hz, 1H), 7.40 (m, 1H), 7.02 (dd, J = 1.0, 8.5 Hz, 1H), 6.89 (m, 1H), 4.65 (m, 1H), 4.50 (dd, J = 9.0, 10.0 Hz, 1H), 4.31 (m, 2H), 4.24 (dd, J = 4.5, 9.5 Hz, 1H), 2.29 (t, J = 7.0 Hz, 2H), 1.66 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H)","125 MHz, CDCl3","173.47, 166.71, 159.96, 133.74, 128.17, 118.73, 116.87, 110.32, 69.13, 65.25, 64.27, 36.13, 18.45, 13.60",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC8703412,"4-Phenoxyphenyl (E)-2-(2-isonicotinoylhydrazineylidene)propanoate (3e). White solid; yield: 60%; mp 152.4–155.0 °C. IR (ATR): 604, 617, 651, 636, 665, 690, 722, 741, 769, 838, 900, 1071, 1094, 1127, 1140, 1185, 1206, 1258, 1375 (CH3), 1487, 1501, 1662, 1673 (CONH), 1754 (COO), 3039, 3260 (N-H) cm−1. 1H NMR (500 MHz, DMSO-d6): δ 11.42 (1H, s, CONHN), 8.80–8.74 (2H, m, H2, H6), 7.81–7.76 (2H, m, H3, H5), 7.43–7.39 (2H, m, H3”, H5”), 7.26–7.14 (3H, H3’, H5’, H4”), 7.09–7.02 (4H, H2’, H6’, H2”, H6”), 2.27 (3H, s, CH3). 13C NMR (126 MHz, DMSO): δ 163.26, 161.90, 156.80, 154.50, 150.18, 146.24, 140.70, 130.29, 123.81, 123.33, 122.49, 119.60, 118.83, 13.66. Elemental analysis; calculated: C, 67.19; H, 4.56; N, 11.19, found: C, 67.24; H, 4.62; N, 11.09. Crystallization from tetrahydrofuran/n-hexane. Rf (S1): 0.32.",4-Phenoxyphenyl (E)-2-(2-isonicotinoylhydrazineylidene)propanoate,C/C(C(OC1=CC=C(OC2=CC=CC=C2)C=C1)=O)=N\NC(C3=CC=NC=C3)=O,"1H NMR (500 MHz, DMSO-d6): δ 11.42 (1H, s, CONHN), 8.80–8.74 (2H, m, H2, H6), 7.81–7.76 (2H, m, H3, H5), 7.43–7.39 (2H, m, H3”, H5”), 7.26–7.14 (3H, H3’, H5’, H4”), 7.09–7.02 (4H, H2’, H6’, H2”, H6”), 2.27 (3H, s, CH3)","13C NMR (126 MHz, DMSO): δ 163.26, 161.90, 156.80, 154.50, 150.18, 146.24, 140.70, 130.29, 123.81, 123.33, 122.49, 119.60, 118.83, 13.66","500 MHz, DMSO-d6","11.42 (1H, s, CONHN), 8.80–8.74 (2H, m, H2, H6), 7.81–7.76 (2H, m, H3, H5), 7.43–7.39 (2H, m, H3”, H5”), 7.26–7.14 (3H, H3’, H5’, H4”), 7.09–7.02 (4H, H2’, H6’, H2”, H6”), 2.27 (3H, s, CH3)","126 MHz, DMSO","163.26, 161.90, 156.80, 154.50, 150.18, 146.24, 140.70, 130.29, 123.81, 123.33, 122.49, 119.60, 118.83, 13.66",34959704.0,Pharmaceuticals (Basel). 2021 Dec 14; 14(12):1302,Pharmaceuticals (Basel),2021.0,CC BY,2021-12-27 23:27:26,no
PMC10056909,"Compound 11h was prepared according to the procedure described for compound 5a, starting from intermediate 3 (50 mg, 0.17 mmol) and 10h (61 mg, 0.17 mmol). The pure product 11h was obtained as a yellow solid (73 mg), yield: 68.1%; M.p.: 203.5–204.4 °C; 1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 1H, indole-2-H), 8.17 (s, 1H, C=CH), 7.99 (d, J = 7.0 Hz, 1H, indole-4-H), 7.80 (d, J = 7.1 Hz, 1H, coumarin-5-H), 7.71 (d, J = 8.2 Hz, 2H, benzene-3,5-2H), 7.63–7.57 (m, 2H, indole-7-H, coumarin-7-H), 7.41–7.36 (m, 2H, coumarin-6-H, coumarin-8-H), 7.31–7.26 (m, 2H, indole-5-H, indole-6-H), 7.08 (d, J = 8.2 Hz, 2H, benzene-2,6-2H), 5.77 (s, 1H, coumarin-3-H), 5.62 (s, 2H, CH2), 3.88 (t, J = 5.0 Hz, 4H, piperazine-3,3′-(CH2)2), 3.38 (t, J = 5.0 Hz, 4H, piperazine-2,2′-(CH2)2) ppm; 13C NMR (101 MHz, DMSO-d6) δ 164.10, 161.45, 160.64, 154.09, 143.54, 137.99, 137.16, 136.36, 132.88, 132.34, 129.99, 128.10, 125.85, 124.27, 123.99, 122.38, 119.43, 118.78, 117.70, 116.13, 111.91, 110.06, 97.45, 97.34, 94.32, 50.73, 49.85, 44.95 ppm; HRMS (ESI) calculated for C32H25IN4O3 [M + H]+, 641.1044; found, 641.1042.",N/A,N/A,"1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 1H, indole-2-H), 8.17 (s, 1H, C=CH), 7.99 (d, J = 7.0 Hz, 1H, indole-4-H), 7.80 (d, J = 7.1 Hz, 1H, coumarin-5-H), 7.71 (d, J = 8.2 Hz, 2H, benzene-3,5-2H), 7.63–7.57 (m, 2H, indole-7-H, coumarin-7-H), 7.41–7.36 (m, 2H, coumarin-6-H, coumarin-8-H), 7.31–7.26 (m, 2H, indole-5-H, indole-6-H), 7.08 (d, J = 8.2 Hz, 2H, benzene-2,6-2H), 5.77 (s, 1H, coumarin-3-H), 5.62 (s, 2H, CH2), 3.88 (t, J = 5.0 Hz, 4H, piperazine-3,3′-(CH2)2), 3.38 (t, J = 5.0 Hz, 4H, piperazine-2,2′-(CH2)2)","13C NMR (101 MHz, DMSO-d6) δ 164.10, 161.45, 160.64, 154.09, 143.54, 137.99, 137.16, 136.36, 132.88, 132.34, 129.99, 128.10, 125.85, 124.27, 123.99, 122.38, 119.43, 118.78, 117.70, 116.13, 111.91, 110.06, 97.45, 97.34, 94.32, 50.73, 49.85, 44.95","400 MHz, DMSO-d6","8.58 (s, 1H, indole-2-H), 8.17 (s, 1H, C=CH), 7.99 (d, J = 7.0 Hz, 1H, indole-4-H), 7.80 (d, J = 7.1 Hz, 1H, coumarin-5-H), 7.71 (d, J = 8.2 Hz, 2H, benzene-3,5-2H), 7.63–7.57 (m, 2H, indole-7-H, coumarin-7-H), 7.41–7.36 (m, 2H, coumarin-6-H, coumarin-8-H), 7.31–7.26 (m, 2H, indole-5-H, indole-6-H), 7.08 (d, J = 8.2 Hz, 2H, benzene-2,6-2H), 5.77 (s, 1H, coumarin-3-H), 5.62 (s, 2H, CH2), 3.88 (t, J = 5.0 Hz, 4H, piperazine-3,3′-(CH2)2), 3.38 (t, J = 5.0 Hz, 4H, piperazine-2,2′-(CH2)2)","101 MHz, DMSO-d6","164.10, 161.45, 160.64, 154.09, 143.54, 137.99, 137.16, 136.36, 132.88, 132.34, 129.99, 128.10, 125.85, 124.27, 123.99, 122.38, 119.43, 118.78, 117.70, 116.13, 111.91, 110.06, 97.45, 97.34, 94.32, 50.73, 49.85, 44.95",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC4828371,"1-(2-Hydroxy-4-((1-octyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-2-(4-isobutylphenyl)propan-1-one (13a) Chemical formula: C30H41N3O3; yield: 85 %; white solid; mp: 84–86 °C; 1H-NMR (300 MHz, CDCl3) δ 12.91 (s, 1H), 7.75 (d, J = 9.03 Hz, 1H), 7.59 (s, 1H), 7.21 (d, J = 8.04 Hz, 2H), 7.10 (d, J = 8.03 Hz, 2H), 6.52 (d, J = 2.44 Hz, 1H), 6.46 (dd, J = 8.95, 2.49 Hz, 1H), 5.22 (s, 2H), 4.64 (q, J = 6.85 Hz, 1H), 4.37 (t, J = 7.27 Hz, 2H), 2.45 (d, J = 7.15 Hz, 2H), 1.96–1.81 (m, 3H), 1.55 (d, J = 6.84 Hz, 3H), 1.32–1.27 (m, 9H), 0.94–0.9 (m, 10H); 13C-NMR (75 MHz, CDCl3) δ 205.1, 166.5, 165.0, 143.9, 141.5, 139.5, 133.2, 130.8 (2C), 128.3 (2C), 123.7, 114.5, 108.9, 103.6, 64.0, 52.5, 48.6, 47.1, 33.9, 32.5, 32.4, 31.3, 31.2, 28.8, 25.0, 24.8 (2C), 21.6, 16.5; LRMS: (ES+) m/z = 492 [M + 1], 514 [M + Na]; HPLC 98.03 %, column: phenomenex luna C8 (2) (250X4.6 mm), mobile phase: 90 % acetonitrile in 0.1 % formic acid, flow rate: 1.0 mL/min.","1-(2-Hydroxy-4-((1-octyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-2-(4-isobutylphenyl)propan-1-one",CC(C1=CC=C(CC(C)C)C=C1)C(C2=CC=C(OCC3=CN(CCCCCCCC)N=N3)C=C2O)=O,"1H-NMR (300 MHz, CDCl3) δ 12.91 (s, 1H), 7.75 (d, J = 9.03 Hz, 1H), 7.59 (s, 1H), 7.21 (d, J = 8.04 Hz, 2H), 7.10 (d, J = 8.03 Hz, 2H), 6.52 (d, J = 2.44 Hz, 1H), 6.46 (dd, J = 8.95, 2.49 Hz, 1H), 5.22 (s, 2H), 4.64 (q, J = 6.85 Hz, 1H), 4.37 (t, J = 7.27 Hz, 2H), 2.45 (d, J = 7.15 Hz, 2H), 1.96–1.81 (m, 3H), 1.55 (d, J = 6.84 Hz, 3H), 1.32–1.27 (m, 9H), 0.94–0.9 (m, 10H)","13C-NMR (75 MHz, CDCl3) δ 205.1, 166.5, 165.0, 143.9, 141.5, 139.5, 133.2, 130.8 (2C), 128.3 (2C), 123.7, 114.5, 108.9, 103.6, 64.0, 52.5, 48.6, 47.1, 33.9, 32.5, 32.4, 31.3, 31.2, 28.8, 25.0, 24.8 (2C), 21.6, 16.5","300 MHz, CDCl3","12.91 (s, 1H), 7.75 (d, J = 9.03 Hz, 1H), 7.59 (s, 1H), 7.21 (d, J = 8.04 Hz, 2H), 7.10 (d, J = 8.03 Hz, 2H), 6.52 (d, J = 2.44 Hz, 1H), 6.46 (dd, J = 8.95, 2.49 Hz, 1H), 5.22 (s, 2H), 4.64 (q, J = 6.85 Hz, 1H), 4.37 (t, J = 7.27 Hz, 2H), 2.45 (d, J = 7.15 Hz, 2H), 1.96–1.81 (m, 3H), 1.55 (d, J = 6.84 Hz, 3H), 1.32–1.27 (m, 9H), 0.94–0.9 (m, 10H)","75 MHz, CDCl3","205.1, 166.5, 165.0, 143.9, 141.5, 139.5, 133.2, 130.8, 128.3, 123.7, 114.5, 108.9, 103.6, 64.0, 52.5, 48.6, 47.1, 33.9, 32.5, 32.4, 31.3, 31.2, 28.8, 25.0, 24.8, 21.6, 16.5",27104111.0,Springerplus. 2016 Apr 11; 5:423,Springerplus,2016.0,CC BY,2021-01-05 05:55:37,no
PMC6152361,"1,2-Diazaspiro[2.5]oct-1-ene-6-carboxylic acid (2d): Pale yellow solid, 1H-NMR (270 MHz, CDCl3) δ ppm: 2.47–2.57 (m, 1H), 2.02–2.11 (m, 2H), 1.82–1.92 (m, 2H), 1.61–1.73 (m, 2H), 0.87 (dt, J = 14.1, 3.6 Hz, 2H); 13C-NMR (68 MHz, CDCl3) 181.6, 41.2, 29.8, 27.3, 26.4; HRMS (ESI) m/z [M + H]+ calcd. for C7H11N2O2 155.0821, found 155.0809.","1,2-Diazaspiro[2.5]oct-1-ene-6-carboxylic acid",O=C(C(CC1)CCC21N=N2)O,"1H-NMR (270 MHz, CDCl3) δ ppm: 2.47–2.57 (m, 1H), 2.02–2.11 (m, 2H), 1.82–1.92 (m, 2H), 1.61–1.73 (m, 2H), 0.87 (dt, J = 14.1, 3.6 Hz, 2H)","13C-NMR (68 MHz, CDCl3) 181.6, 41.2, 29.8, 27.3, 26.4","270 MHz, CDCl3","2.47–2.57 (m, 1H), 2.02–2.11 (m, 2H), 1.82–1.92 (m, 2H), 1.61–1.73 (m, 2H), 0.87 (dt, J = 14.1, 3.6 Hz, 2H)","68 MHz, CDCl3","181.6, 41.2, 29.8, 27.3, 26.4",28829361.0,Molecules. 2017 Aug 22; 22(8):1389,Molecules,2017.0,CC BY,2021-01-05 20:55:12,no
PMC4939320,"Benzyl (3-hydroperoxy-3-hydroxypropyl)carbamate (7): Colorless; 1H NMR (600 MHz, H2O–D2O 67:33): δ=7.39–7.29 (br m, 5H), 5.09 (t, J=5.8, 1H), 5.04 (br s, 2H), 3.17 (br m, 2H), 1.74 (m, 1H), 1.69 (m, 1H); 13C NMR (150 MHz, CDCl3): δ=158.1, 136.4, 128.9, 128.5, 128.3, 99.3, 66.8, 36.5, 32.4; HPLC-MS-ESI+: m/z=264.0856, calcd. for C11H15NO5: 264.0842.",Benzyl (3-hydroperoxy-3-hydroxypropyl)carbamate,O=C(OCC1=CC=CC=C1)NCCC(OO)O,"1H NMR (600 MHz, H2O–D2O 67:33): δ=7.39–7.29 (br m, 5H), 5.09 (t, J=5.8, 1H), 5.04 (br s, 2H), 3.17 (br m, 2H), 1.74 (m, 1H), 1.69 (m, 1H)","13C NMR (150 MHz, CDCl3): δ=158.1, 136.4, 128.9, 128.5, 128.3, 99.3, 66.8, 36.5, 32.4","600 MHz, H2O–D2O 67:33","7.39–7.29 (br m, 5H), 5.09 (t, J=5.8, 1H), 5.04 (br s, 2H), 3.17 (br m, 2H), 1.74 (m, 1H), 1.69 (m, 1H)","150 MHz, CDCl3","158.1, 136.4, 128.9, 128.5, 128.3, 99.3, 66.8, 36.5, 32.4",27437440.0,Data Brief. 2016 Jun 23; 8:659-665,Data Brief,2016.0,CC BY,2021-01-05 06:45:13,no
PMC6337571,"Ethyl (S*)-4-(6-azido-9H-purin-9-yl)cyclopent-1-ene-1-carboxylate, (±)-20.White solid, m.p. 145–147 °C, 68%; 1H-NMR (DMSO, 400 MHz): δ (ppm) = 1.22 (t, 3H, CH3, J = 7.08 Hz), 2.97–3.09 (m, 2H, CH2), 3.22–3.28 (m, 2H, CH2), 4.12–4.23 (m, 2H, OCH2), 5.53–5.64 (m, 1H, H-4), 6.86–6.89 (m, 1H, H-2), 8.66 (s, 1H, Ar-H), 10.07 (s, 1H, Ar-H); 13C-NMR (DMSO, 100 MHz): δ (ppm) = 15.0, 34.9, 39.2, 55.1, 61.0, 121.2, 134.5, 136.3, 141.8, 142.8, 143.8, 146.3, 164.5; MS (ES, pos) m/z = 300 (M + 1).",Ethyl (S*)-4-(6-azido-9H-purin-9-yl)cyclopent-1-ene-1-carboxylate,O=C(C1=CC[C@H](N2C=NC3=C(N=[N+]=[N-])N=CN=C23)C1)OCC,"1H-NMR (DMSO, 400 MHz): δ (ppm) = 1.22 (t, 3H, CH3, J = 7.08 Hz), 2.97–3.09 (m, 2H, CH2), 3.22–3.28 (m, 2H, CH2), 4.12–4.23 (m, 2H, OCH2), 5.53–5.64 (m, 1H, H-4), 6.86–6.89 (m, 1H, H-2), 8.66 (s, 1H, Ar-H), 10.07 (s, 1H, Ar-H)","13C-NMR (DMSO, 100 MHz): δ (ppm) = 15.0, 34.9, 39.2, 55.1, 61.0, 121.2, 134.5, 136.3, 141.8, 142.8, 143.8, 146.3, 164.5","DMSO, 400 MHz","1.22 (t, 3H, CH3, J = 7.08 Hz), 2.97–3.09 (m, 2H, CH2), 3.22–3.28 (m, 2H, CH2), 4.12–4.23 (m, 2H, OCH2), 5.53–5.64 (m, 1H, H-4), 6.86–6.89 (m, 1H, H-2), 8.66 (s, 1H, Ar-H), 10.07 (s, 1H, Ar-H)","DMSO, 100 MHz","15.0, 34.9, 39.2, 55.1, 61.0, 121.2, 134.5, 136.3, 141.8, 142.8, 143.8, 146.3, 164.5",30609864.0,Molecules. 2019 Jan 3; 24(1):161,Molecules,2019.0,CC BY,2021-01-05 22:44:29,no
PMC3413882,"Azide 8 (20 mg, 0.023 mmol) and alkyne 9d (6.7 mg, 0.023 mmol) were reacted according to Section 4.3.3. After 10 h, work-up and purification of the residue by flash column chromatography (20% MeOH in CHCl3) afforded 1,2,3-triazole 10d as a colourless paste (20 mg, 87%): Rf = 0.28 (20% MeOH in CHCl3); IR (KBr) ν 3368m br (O–H), 2917s, 2848s, 1635m (CO), 1550w, 1467s, 1348w, 1231w, 1145m, 1070s, 1035s, 1001w, 785w, 719m, 685m; 1H NMR (300 MHz, CDCl3/CD3OD, 2:1) δ 0.84 (app. t, 6H, J 6.5 Hz), 1.13–1.39 (stack, 68H), 1.44–1.68 (stack, 4H), 2.13 (app. t, 2H, J 7.4 Hz), 3.33–3.41 (stack including [3.35 (s, 3H)], 4H), 3.42–3.50 (stack, 3H), 3.50–3.55 (stack, 2H), 3.58–3.65 (stack, 18H), 3.69 (dd, 1H, J 9.6, 3.2 Hz), 3.74–3.82 (stack, 2H), 4.04–4.12 (m, 1H), 4.17 (app. t, 1H, J 6.7 Hz), 4.52–4.58 (m, 2H), 4.62 (s, 2H), 4.85 (d, 1H, J 3.6 Hz), 7.80 (s, 1H), exchangeable protons not observed; 13C NMR (75 MHz, CDCl3/CD3OD, 2:1) δ 14.3 (CH3), [23.0, 26.2, 29.7, 29.8, 30.1, 32.3, 32.9, 36.8 (CH2, some overlapping alkyl resonances)], 50.5 (CH), 51.3 (CH2), 59.1 (CH3), 64.6 (CH2), 67.5 (CH2), 69.0 (CH), 69.7 (CH), 69.8 (CH), 70.0 (CH2), 70.3 (CH), [70.66, 70.79 (CH2, some overlapping ethylene glycol resonances)], 72.2 (CH2), 72.3 (CH), 75.0 (CH), 100.0 (CH), 125.1 (CH), 145.0 (quat. C), 174.7 (quat. C); m/z (TOF ES+) 1196.6 ([M+Na]+, 100%); HRMS m/z (TOF ES+) 1195.9045. C64H124N4NaO14 requires 1195.9045.","1,2,3-triazole",N/A,"1H NMR (300 MHz, CDCl3/CD3OD, 2:1) δ 0.84 (app. t, 6H, J 6.5 Hz), 1.13–1.39 (stack, 68H), 1.44–1.68 (stack, 4H), 2.13 (app. t, 2H, J 7.4 Hz), 3.33–3.41 (stack including [3.35 (s, 3H)], 4H), 3.42–3.50 (stack, 3H), 3.50–3.55 (stack, 2H), 3.58–3.65 (stack, 18H), 3.69 (dd, 1H, J 9.6, 3.2 Hz), 3.74–3.82 (stack, 2H), 4.04–4.12 (m, 1H), 4.17 (app. t, 1H, J 6.7 Hz), 4.52–4.58 (m, 2H), 4.62 (s, 2H), 4.85 (d, 1H, J 3.6 Hz), 7.80 (s, 1H)","13C NMR (75 MHz, CDCl3/CD3OD, 2:1) δ 14.3 (CH3), [23.0, 26.2, 29.7, 29.8, 30.1, 32.3, 32.9, 36.8 (CH2, some overlapping alkyl resonances)], 50.5 (CH), 51.3 (CH2), 59.1 (CH3), 64.6 (CH2), 67.5 (CH2), 69.0 (CH), 69.7 (CH), 69.8 (CH), 70.0 (CH2), 70.3 (CH), [70.66, 70.79 (CH2, some overlapping ethylene glycol resonances)], 72.2 (CH2), 72.3 (CH), 75.0 (CH), 100.0 (CH), 125.1 (CH), 145.0 (quat. C), 174.7 (quat. C)","300 MHz, CDCl3/CD3OD, 2:1","0.84 (app. t, 6H, J 6.5 Hz), 1.13–1.39 (stack, 68H), 1.44–1.68 (stack, 4H), 2.13 (app. t, 2H, J 7.4 Hz), 3.33–3.41 (stack including [3.35 (s, 3H)], 4H), 3.42–3.50 (stack, 3H), 3.50–3.55 (stack, 2H), 3.58–3.65 (stack, 18H), 3.69 (dd, 1H, J 9.6, 3.2 Hz), 3.74–3.82 (stack, 2H), 4.04–4.12 (m, 1H), 4.17 (app. t, 1H, J 6.7 Hz), 4.52–4.58 (m, 2H), 4.62 (s, 2H), 4.85 (d, 1H, J 3.6 Hz), 7.80 (s, 1H)","75 MHz, CDCl3/CD3OD, 2:1","14.3, 23.0, 26.2, 29.7, 29.8, 30.1, 32.3, 32.9, 36.8, 50.5, 51.3, 59.1, 64.6, 67.5, 69.0, 69.7, 69.8, 70.0, 70.3, 70.66, 70.79, 72.2, 72.3, 75.0, 100.0, 125.1, 145.0, 174.7",22445102.0,Carbohydr Res. 2012 Jul 15; 356(9-10):152-162,Carbohydr Res,2012.0,CC BY,2022-02-12 23:20:27,no
PMC8826940,"4-(2-aminoethoxy) rhodamine (compound 4): to a solution of compound 3 (0.12 g, 0.19 mmol) in absolute ethanol (5 mL) was added hydrazine monohydrate (0.09 g, 1.95 mmol). The resulting mixture was refluxed for 4 h. The solvent was removed under reduced pressure and 20 ml of CH2Cl2 was added to the mixture. The organic layer was washed with 10 ml of NaOH solution (10−4 mol L−1) and was dried with MgSO4 to provide 70 mg of free amine 4 (82%), which was used without any further purification. 1H NMR (CD3OD, 400 MHz): δ = 7.33 (d, J = 8 Hz, 2 H, Ar-H), 7.21 (d, J = 8 Hz, 2 H, Ar-H), 6.94 (s, 2 H, Ar-H), 4.21 (t, J = 4 Hz, 2 H, CH2), 3.70 (t, J = 4 Hz, 2 H, CH2), 3.50–3.56 (m, 8 H, CH2), 3.06 (t, J = 8 Hz, 4 H, CH2), 2.72 (t, J = 8 Hz, 4 H, CH2), 2.08–2.11 (m, 4 H, CH2) and 1.95–1.96 (m, 4 H, CH2) ppm. 13C NMR (CD3OD, 100 MHz): δ = 160.17, 154.90, 152.31, 151.02, 131.08, 126.46, 125.02, 123.79, 114.53, 112.66, 105.27, 50.48, 49.98, 40.16, 29.42, 27.29, 20.48, 19.63 and 19.53 ppm. HRMS (TOF MS ES+): found: [M]+ = 506.2811; Calc. for C33H36N3O2+: [M]+ = 506.2802.",4-(2-aminoethoxy) rhodamine,N/A,"1H NMR (CD3OD, 400 MHz): δ = 7.33 (d, J = 8 Hz, 2 H, Ar-H), 7.21 (d, J = 8 Hz, 2 H, Ar-H), 6.94 (s, 2 H, Ar-H), 4.21 (t, J = 4 Hz, 2 H, CH2), 3.70 (t, J = 4 Hz, 2 H, CH2), 3.50–3.56 (m, 8 H, CH2), 3.06 (t, J = 8 Hz, 4 H, CH2), 2.72 (t, J = 8 Hz, 4 H, CH2), 2.08–2.11 (m, 4 H, CH2) and 1.95–1.96 (m, 4 H, CH2) ppm","13C NMR (CD3OD, 100 MHz): δ = 160.17, 154.90, 152.31, 151.02, 131.08, 126.46, 125.02, 123.79, 114.53, 112.66, 105.27, 50.48, 49.98, 40.16, 29.42, 27.29, 20.48, 19.63 and 19.53 ppm","CD3OD, 400 MHz","7.33 (d, J = 8 Hz, 2 H, Ar-H), 7.21 (d, J = 8 Hz, 2 H, Ar-H), 6.94 (s, 2 H, Ar-H), 4.21 (t, J = 4 Hz, 2 H, CH2), 3.70 (t, J = 4 Hz, 2 H, CH2), 3.50–3.56 (m, 8 H, CH2), 3.06 (t, J = 8 Hz, 4 H, CH2), 2.72 (t, J = 8 Hz, 4 H, CH2), 2.08–2.11 (m, 4 H, CH2), 1.95–1.96 (m, 4 H, CH2)","CD3OD, 100 MHz","160.17, 154.90, 152.31, 151.02, 131.08, 126.46, 125.02, 123.79, 114.53, 112.66, 105.27, 50.48, 49.98, 40.16, 29.42, 27.29, 20.48, 19.63, 19.53",35136061.0,Nat Commun. 2022 Feb 8; 13:753,Nat Commun,2022.0,CC BY,2022-03-24 23:25:11,no
PMC10045663,"(E)-16-Benzylidene-3-hydroxy-5α,6α-epoxy-10,13-dimethyl-1,3,4,7,8,9,10,11,12,13,15,16-dodecahydro-2H-cyclopenta[α]phenanthrene-17(14H)-one (15) White powder (78%); m.p. 207–208 °C; m.p. literature [207–209 °C]; IR (cm−1): 3190, 2943, 2859, 1725, 1628. 1H NMR (CDCl3 400.13 MHz) δ: 7.51 (2H, d, J = 8.1 Hz), 7.42–7.32 (4H, m), 3.94–3.84 (1H, m), 2.95 (1H, d, J = 4.4 Hz), 2.85 (1H, dd, J = 16.1, 6.4 Hz), 1.11 (3H, s), and 0.90 (3H, s). 13C NMR (CDCl3 101.62 MHz) δ: 209.20, 135.58, 135.28, 130.33, 129.30, 128.71, 68.57, 65.87, 65.69, 58.70, 49.95, 47.41, 42.84, 39.76, 35.14, 32.37, 31.20, 31.07, 29.24, 27.90, 20.06, 15.99, 15.29, 14.28 [25].","(E)-16-Benzylidene-3-hydroxy-5α,6α-epoxy-10,13-dimethyl-1,3,4,7,8,9,10,11,12,13,15,16-dodecahydro-2H-cyclopenta[α]phenanthrene-17(14H)-one",N/A,"1H NMR (CDCl3 400.13 MHz) δ: 7.51 (2H, d, J = 8.1 Hz), 7.42–7.32 (4H, m), 3.94–3.84 (1H, m), 2.95 (1H, d, J = 4.4 Hz), 2.85 (1H, dd, J = 16.1, 6.4 Hz), 1.11 (3H, s), and 0.90 (3H, s)","13C NMR (CDCl3 101.62 MHz) δ: 209.20, 135.58, 135.28, 130.33, 129.30, 128.71, 68.57, 65.87, 65.69, 58.70, 49.95, 47.41, 42.84, 39.76, 35.14, 32.37, 31.20, 31.07, 29.24, 27.90, 20.06, 15.99, 15.29, 14.28",CDCl3 400.13 MHz,"7.51 (2H, d, J = 8.1 Hz), 7.42–7.32 (4H, m), 3.94–3.84 (1H, m), 2.95 (1H, d, J = 4.4 Hz), 2.85 (1H, dd, J = 16.1, 6.4 Hz), 1.11 (3H, s), 0.90 (3H, s)",CDCl3 101.62 MHz,"209.20, 135.58, 135.28, 130.33, 129.30, 128.71, 68.57, 65.87, 65.69, 58.70, 49.95, 47.41, 42.84, 39.76, 35.14, 32.37, 31.20, 31.07, 29.24, 27.90, 20.06, 15.99, 15.29, 14.28",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6256927,"N,N′-Dihexadecyl-2,3-dihydroxybutanediamide (5h). Yield: 96%; m.p. 157–159 °C; 1H-NMR (CDCl3) δ: 7.08 (2H; t; NH; J = 6 Hz), 5.70 (0.34H; s; OH), 5.50 (1.66H; d; OH; J = 6.6 Hz), 4.23 (1.66H; d; CH; J = 6.6 Hz), 4.00 (0.34H; s; CH), 3.29 (0.68H; m; NH-CH2), 3.24 (3.32H; m; NH-CH2), 1.50 (4H; tt; NH-CH2-CH2; J = 7.2, 6.6 Hz), 1.38–1.22 (52H; m; CH2), 0.88 (6H; t; CH3; J = 6.8 Hz); 13C-NMR (CDCl3) δ: 173.6, 70.8, 39.8, 32.6, 30.39, 30.37, 30.35, 30.32, 30.29, 30.26, 30.22, 30.19, 30.05, 30.01, 29.92, 27.5, 23.3, 14.8; isomer ratio (RR/RS:SR): 86:14; MS (ESI) m/z: 597 (MH+).","N,N′-Dihexadecyl-2,3-dihydroxybutanediamide",N/A,"1H-NMR (CDCl3) δ: 7.08 (2H; t; NH; J = 6 Hz), 5.70 (0.34H; s; OH), 5.50 (1.66H; d; OH; J = 6.6 Hz), 4.23 (1.66H; d; CH; J = 6.6 Hz), 4.00 (0.34H; s; CH), 3.29 (0.68H; m; NH-CH2), 3.24 (3.32H; m; NH-CH2), 1.50 (4H; tt; NH-CH2-CH2; J = 7.2, 6.6 Hz), 1.38–1.22 (52H; m; CH2), 0.88 (6H; t; CH3; J = 6.8 Hz)","13C-NMR (CDCl3) δ: 173.6, 70.8, 39.8, 32.6, 30.39, 30.37, 30.35, 30.32, 30.29, 30.26, 30.22, 30.19, 30.05, 30.01, 29.92, 27.5, 23.3, 14.8",CDCl3,"7.08 (2H; t; NH; J = 6 Hz), 5.70 (0.34H; s; OH), 5.50 (1.66H; d; OH; J = 6.6 Hz), 4.23 (1.66H; d; CH; J = 6.6 Hz), 4.00 (0.34H; s; CH), 3.29 (0.68H; m; NH-CH2), 3.24 (3.32H; m; NH-CH2), 1.50 (4H; tt; NH-CH2-CH2; J = 7.2, 6.6 Hz), 1.38–1.22 (52H; m; CH2), 0.88 (6H; t; CH3; J = 6.8 Hz)",CDCl3,"173.6, 70.8, 39.8, 32.6, 30.39, 30.37, 30.35, 30.32, 30.29, 30.26, 30.22, 30.19, 30.05, 30.01, 29.92, 27.5, 23.3, 14.8",20335949.0,Molecules. 2010 Feb 5; 15(2):824-833,Molecules,2010.0,CC BY,2021-01-05 21:52:27,no
PMC8359580,"Additional file 3: Figure S1.1H-NMR and 13C-NMR spectra of N-D3-acetyltyramine-O,β-glucuronide (D3-NATOG) and intermediates of synthesis.","N-D3-acetyltyramine-O,β-glucuronide",N/A,"1H-NMR and 13C-NMR spectra of N-D3-acetyltyramine-O,β-glucuronide (D3-NATOG) and intermediates of synthesis","1H-NMR and 13C-NMR spectra of N-D3-acetyltyramine-O,β-glucuronide (D3-NATOG) and intermediates of synthesis",N/A,N/A,N/A,N/A,34380554.0,Parasit Vectors. 2021 Aug 11; 14:397,Parasit Vectors,2021.0,CC BY,2021-09-04 01:11:27,no
PMC8471275,"Methyl 5-nitro-6-(4-nitrophenoxy)nicotinate (2e). 93%. M.p. 128–130 °C. 1H NMR (300 MHz, CDCl3): δ 4.00 (s, 3H, CO2CH3), 7.39 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.36 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.93 (s, 1H, C(4)-H), 8.97 (s, 1H, C(6)-H). 13C NMR (75 MHz, CDCl3): δ 53.0, 122.6, 122.8, 125.9, 134.0, 136.9, 145.6, 152.9, 156.8, 163.2. HRMS (ESI) calc. for [C13H9N3O7]+ [M + H]+ 320.0503, found 320.0513.",Methyl 5-nitro-6-(4-nitrophenoxy)nicotinate,O=C(OC)C1=CN=C(OC2=CC=C([N+]([O-])=O)C=C2)C([N+]([O-])=O)=C1,"1H NMR (300 MHz, CDCl3): δ 4.00 (s, 3H, CO2CH3), 7.39 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.36 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.93 (s, 1H, C(4)-H), 8.97 (s, 1H, C(6)-H)","13C NMR (75 MHz, CDCl3): δ 53.0, 122.6, 122.8, 125.9, 134.0, 136.9, 145.6, 152.9, 156.8, 163.2","300 MHz, CDCl3","4.00 (s, 3H, CO2CH3), 7.39 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.36 (d, J = 9.0 Hz, 2H, 4-NO2-Ph), 8.93 (s, 1H, C(4)-H), 8.97 (s, 1H, C(6)-H)","75 MHz, CDCl3","53.0, 122.6, 122.8, 125.9, 134.0, 136.9, 145.6, 152.9, 156.8, 163.2",34577019.0,Molecules. 2021 Sep 13; 26(18):5547,Molecules,2021.0,CC BY,2021-11-06 00:08:06,no
PMC7073722,"To a solution of ricinoleic acid (12) (21 g, technical, ~80% pure, ca. 56 mmol) in methanol (140 mL) with stirring, was added BF3.2MeOH (3.85 mL, 35.5 mmol, 0.63 equiv). Stirring was continued overnight at 50 °C. TLC monitoring showed completion of the reaction mixture after 16 h. Methanol was removed in vacuo, and the resulting oily residue was transferred into a separating funnel with ethyl acetate (100 mL). After washing with brine (3 × 30 mL) and drying over Na2SO4, ethyl acetate was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (86 g, 0–4% acetone in petroleum ether) to afford methyl ricinoleate 13 as a colorless oil (16.59 g, 75%) along with a small amount (4%) of a slightly less polar by-product 14. It eluted after a minor amount of a less polar mixture of methyl oleate and methyl linoleate, Rf ca. 0.75 (petroleum ether/acetone 80:20), which was the result of the esterification of the ~15% oleic + linoleic acids, which were contained in technical ricinoleic acid. When potassium carbonate (600 mg) was added to a solution of 13 containing 14 (3.17 g) in methanol (30 mL) with stirring for 42 h (followed by quenching with a solution of citric acid (834 mg) in water (7.5 mL)), the by-product 14 disappeared to afford compound 13 alone, Rf = 0.4 (petroleum ether/acetone 80:20).  IR (KBr) ν 3445 (broad, O–H), 3007, 2928, 2855, 1741 (C=O), 1461, 1436, 1246, 1198, 1173, 725 cm−1.  1H NMR (400 MHz, CDCl3): δ 5.56 (dtt, 1H, J = 10.9, 7.3, 1.5 Hz, CH=CH–CH2–CHOH), 5.40 (dtt, 1H, J = 10.9, 7.5, 1.5 Hz, CH=CH–CH2–CHOH), 3.67 (s, 3H, CO2Me), 3.66–3.56 (m, 1H, CHOH), 2.30 (dd, 2H, J = 7.7, 7.4 Hz, CH2CO2Me), 2.24–2.18 (m, 2H, CHOH–CH2–CH=CH), 2.05 (br qd, 2H, J = 7.2, 1.2 Hz, CH=CH–CH2), 1.62 (br tt, 2H, J = 7.5, 7.3 Hz, CH2CH2CO2Me), 1.58 (br d, 1H, J = 0.9 Hz, OH, could be s and overlapped at another δ), 1.51–1.41 (m, 3H, CH2CHOH and 1H of CH2CH2CHOH), 1.39–1.23 (m, 15H, 1H of CH2CH2CHOH, CH3(CH2)3 and (CH2)4CH2CH2CO2Me), 0.88 (t (approximately t because not first order due to coupling to a rather close CH2 at ~1.25 ppm), 3H, J = 6.9 Hz, CH3). 13C NMR (100 MHz, CDCl3): δ 174.35 (Cquat, CO), 133.39 (CH=CH), 125.24 (CH=CH), 71.52 (CHOH), 51.46 (CO2CH3), 36.87 (CH2), 35.37 (CH2), 34.10 (CH2CO2Me), 31.85 (CH2CH2CH3), 29.58 (CH2), 29.37 (CH2), 29.13 (CH2), 29.10 (2 CH2), 27.38 (CH2), 25.73 (CH2), 24.93 (CH2CH2CO2Me), 22.63 (CH2CH3), 14.10 (CH3).  [α]D22: +4.2; [α]57822: +4.3; [α]54622: +4.7; [α]43622: +7.0; [α]36522: +8.7 (c 6.00, CHCl3),",methyl ricinoleate,O[C@H](CCCCCC)C/C=C\CCCCCCCC(OC)=O,"1H NMR (400 MHz, CDCl3): δ 5.56 (dtt, 1H, J = 10.9, 7.3, 1.5 Hz, CH=CH–CH2–CHOH), 5.40 (dtt, 1H, J = 10.9, 7.5, 1.5 Hz, CH=CH–CH2–CHOH), 3.67 (s, 3H, CO2Me), 3.66–3.56 (m, 1H, CHOH), 2.30 (dd, 2H, J = 7.7, 7.4 Hz, CH2CO2Me), 2.24–2.18 (m, 2H, CHOH–CH2–CH=CH), 2.05 (br qd, 2H, J = 7.2, 1.2 Hz, CH=CH–CH2), 1.62 (br tt, 2H, J = 7.5, 7.3 Hz, CH2CH2CO2Me), 1.58 (br d, 1H, J = 0.9 Hz, OH, could be s and overlapped at another δ), 1.51–1.41 (m, 3H, CH2CHOH and 1H of CH2CH2CHOH), 1.39–1.23 (m, 15H, 1H of CH2CH2CHOH, CH3(CH2)3 and (CH2)4CH2CH2CO2Me), 0.88 (t (approximately t because not first order due to coupling to a rather close CH2 at ~1.25 ppm), 3H, J = 6.9 Hz, CH3)","13C NMR (100 MHz, CDCl3): δ 174.35 (Cquat, CO), 133.39 (CH=CH), 125.24 (CH=CH), 71.52 (CHOH), 51.46 (CO2CH3), 36.87 (CH2), 35.37 (CH2), 34.10 (CH2CO2Me), 31.85 (CH2CH2CH3), 29.58 (CH2), 29.37 (CH2), 29.13 (CH2), 29.10 (2 CH2), 27.38 (CH2), 25.73 (CH2), 24.93 (CH2CH2CO2Me), 22.63 (CH2CH3), 14.10 (CH3)","400 MHz, CDCl3","5.56 (dtt, 1H, J = 10.9, 7.3, 1.5 Hz, CH=CH–CH2–CHOH), 5.40 (dtt, 1H, J = 10.9, 7.5, 1.5 Hz, CH=CH–CH2–CHOH), 3.67 (s, 3H, CO2Me), 3.66–3.56 (m, 1H, CHOH), 2.30 (dd, 2H, J = 7.7, 7.4 Hz, CH2CO2Me), 2.24–2.18 (m, 2H, CHOH–CH2–CH=CH), 2.05 (br qd, 2H, J = 7.2, 1.2 Hz, CH=CH–CH2), 1.62 (br tt, 2H, J = 7.5, 7.3 Hz, CH2CH2CO2Me), 1.58 (br d, 1H, J = 0.9 Hz, OH, could be s and overlapped at another δ), 1.51–1.41 (m, 3H, CH2CHOH and 1H of CH2CH2CHOH), 1.39–1.23 (m, 15H, 1H of CH2CH2CHOH, CH3(CH2)3 and (CH2)4CH2CH2CO2Me), 0.88 (t (approximately t because not first order due to coupling to a rather close CH2 at ~1.25 ppm), 3H, J = 6.9 Hz, CH3)","100 MHz, CDCl3","174.35, 133.39, 125.24, 71.52, 51.46, 36.87, 35.37, 34.10, 31.85, 29.58, 29.37, 29.13, 29.10, 27.38, 25.73, 24.93, 22.63, 14.10",32075231.0,Mar Drugs. 2020 Feb 15; 18(2):113,Mar Drugs,2020.0,CC BY,2022-10-27 23:15:30,no
PMC10096054,"(1-methoxy-2,2,5,5-tetramethyl-4-(pyren-1-yl)-2,5-dihydro-1H-pyrrol-3-yl)methanol (6): To a stirred solution of compound 5 (450 mg, 1.1 mmol) in Et2O (10 mL), LiAlH4 (114 mg, 3.0 mmol) was added under N2. The solution was stirred at room temperature until the complete consumption of the starting material (TLC monitoring); then, the solution was poured onto 10% aq. NaOH solution and crushed ice; then, it was diluted with Et2O (20 mL). The organic phase was separated, and the aqueous phase was extracted with CHCl3 (2 × 20 mL). The combined organic phase was dried (MgSO4), filtered, evaporated, and after flash column chromatography, compound 6 was obtained as a white solid (330 mg, 77%). Mp. 139–140 °C; TLC Rf = 0.35 (Hexane/Et2O 1:1); MS (EI) m/z (% relative intensity) = 385 (M+, 8.00), 370 (100), 339 (14.4), 309 (27.8); IR ν− = 3301, 3044, 2924, 1600, 853 cm−1; 1H NMR (CDCl3): δ 1.31 (s, 6C, -CH3), 1.57 (s, 3H, -CH3), 1.68 (s, 3H, -CH3), 3.87 (s, 3H, -OCH3), 3.94 (s, 2H, -CH2-), 7.84 (d, J = 8.0 Hz, 1H, Ar-H), 8.06 (t, J = 7.5 Hz, 1H, Ar-H), 8.10–8.25 (m, 7H, Ar-H); 13C NMR (CDCl3): δ 22.5, 29.5, 57.9, 65.4, 69.9, 71.7, 124.3, 124.8, 124.9, 125.2, 125.4, 126.2, 127.4, 127.6, 127.9, 130.1, 130.2, 130.8, 131.0, 131.4, 141.3, 141.9. Anal. calcd. for C26H27NO2: C, 81.01; H, 7.06; N, 3.63%; found: C, 81.04; H, 7.05; N, 3.64%.  3.2. Methods","(1-methoxy-2,2,5,5-tetramethyl-4-(pyren-1-yl)-2,5-dihydro-1H-pyrrol-3-yl)methanol",OCC1=C(C2=C(C3=C45)C=CC5=CC=CC4=CC=C3C=C2)C(C)(C)N(OC)C1(C)C,"1H NMR (CDCl3): δ 1.31 (s, 6C, -CH3), 1.57 (s, 3H, -CH3), 1.68 (s, 3H, -CH3), 3.87 (s, 3H, -OCH3), 3.94 (s, 2H, -CH2-), 7.84 (d, J = 8.0 Hz, 1H, Ar-H), 8.06 (t, J = 7.5 Hz, 1H, Ar-H), 8.10–8.25 (m, 7H, Ar-H)","13C NMR (CDCl3): δ 22.5, 29.5, 57.9, 65.4, 69.9, 71.7, 124.3, 124.8, 124.9, 125.2, 125.4, 126.2, 127.4, 127.6, 127.9, 130.1, 130.2, 130.8, 131.0, 131.4, 141.3, 141.9",CDCl3,"1.31 (s, 6C, -CH3), 1.57 (s, 3H, -CH3), 1.68 (s, 3H, -CH3), 3.87 (s, 3H, -OCH3), 3.94 (s, 2H, -CH2-), 7.84 (d, J = 8.0 Hz, 1H, Ar-H), 8.06 (t, J = 7.5 Hz, 1H, Ar-H), 8.10–8.25 (m, 7H, Ar-H)",CDCl3,"22.5, 29.5, 57.9, 65.4, 69.9, 71.7, 124.3, 124.8, 124.9, 125.2, 125.4, 126.2, 127.4, 127.6, 127.9, 130.1, 130.2, 130.8, 131.0, 131.4, 141.3, 141.9",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC8695447,"N-(4-Methyl-3-(1-methyl-2-oxo-7-((4-(piperidin-1-yl)phenyl)amino)-1,4-dihydropyrimido[4,5-d]pyrimidin-3(2H)-yl)phenyl)-3-(trifluoromethyl)benzamide (1). To a solution of N-(3-(7-chloro-1-methyl-2-oxo-1,4-dihydropyrimido[4,5-d]pyrimidin-3(2H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide (27) (100 mg, 0.211 mmol) in 2-butanol (2 ml) was added 4-(piperidin-1-yl)aniline (41 mg, 0.232 mmol), K2CO3 (690 mg, 1.055 mmol), Xphos (20 mg, 0.042 mmol) and Pd2(dba)3 (40 mg, 0.042 mmol) at room temperature. The reaction mixture was then stirred for 1 h at 100°C, cooled to room temperature, filtered and concentrated. The resulting residue was purified by silica gel column chromatography on silica gel (10 to 50% THF/hexane) to afford 1 (92 mg, 71%) as a brown solid. 1H NMR (300 MHz, DMSO-d 6) δ 10.52 (s, 1H), 9.29 (s, 1H), 8.31–8.25 (m, 2H), 8.09 (s, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.82–7.76 (m, 2H), 7.65 (dd, J = 1.9 Hz, 8.3 Hz, 1H), 7.59–7.56 (m, 2H), 7.31 (d, J = 8.3 Hz, 1H), 6.89–6.86 (d, J = 9.1 Hz, 2H), 4.68 (d, J = 14.0 Hz, 1H), 4.49 (d, J = 14.0 Hz, 1H), 3.5–3.02 (m, 4H), 2.14 (s, 3H), 1.66–1.61 (m, 4H), 1.52–1.50 (m, 2H); 13C NMR (75.5 MHz, DMSO-d 6) δ 163.9, 159.2, 156.9, 153.2, 152.3, 147.0, 141.3, 137.6, 135.6, 132.5, 131.8, 131.0, 130.8, 129.8, 129.4, 129.0, 128.2, 125.8, 124.2, 124.2, 122.2, 120.2, 119.8, 119.4, 116.5, 101.8, 50.5, 46.7, 28.2, 25.5, 23.9, 16.8. LCMS (ESI) m/z 616 [M + H]+.","N-(4-Methyl-3-(1-methyl-2-oxo-7-((4-(piperidin-1-yl)phenyl)amino)-1,4-dihydropyrimido[4,5-d]pyrimidin-3(2H)-yl)phenyl)-3-(trifluoromethyl)benzamide",O=C(NC1=CC=C(C)C(N2CC3=CN=C(NC4=CC=C(N5CCCCC5)C=C4)N=C3N(C)C2=O)=C1)C6=CC=CC(C(F)(F)F)=C6,"1H NMR (300 MHz, DMSO-d 6) δ 10.52 (s, 1H), 9.29 (s, 1H), 8.31–8.25 (m, 2H), 8.09 (s, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.82–7.76 (m, 2H), 7.65 (dd, J = 1.9 Hz, 8.3 Hz, 1H), 7.59–7.56 (m, 2H), 7.31 (d, J = 8.3 Hz, 1H), 6.89–6.86 (d, J = 9.1 Hz, 2H), 4.68 (d, J = 14.0 Hz, 1H), 4.49 (d, J = 14.0 Hz, 1H), 3.5–3.02 (m, 4H), 2.14 (s, 3H), 1.66–1.61 (m, 4H), 1.52–1.50 (m, 2H)","13C NMR (75.5 MHz, DMSO-d 6) δ 163.9, 159.2, 156.9, 153.2, 152.3, 147.0, 141.3, 137.6, 135.6, 132.5, 131.8, 131.0, 130.8, 129.8, 129.4, 129.0, 128.2, 125.8, 124.2, 124.2, 122.2, 120.2, 119.8, 119.4, 116.5, 101.8, 50.5, 46.7, 28.2, 25.5, 23.9, 16.8","300 MHz, DMSO-d 6","10.52 (s, 1H), 9.29 (s, 1H), 8.31–8.25 (m, 2H), 8.09 (s, 1H), 7.97 (d, J = 8.0 Hz, 1H), 7.82–7.76 (m, 2H), 7.65 (dd, J = 1.9 Hz, 8.3 Hz, 1H), 7.59–7.56 (m, 2H), 7.31 (d, J = 8.3 Hz, 1H), 6.89–6.86 (d, J = 9.1 Hz, 2H), 4.68 (d, J = 14.0 Hz, 1H), 4.49 (d, J = 14.0 Hz, 1H), 3.5–3.02 (m, 4H), 2.14 (s, 3H), 1.66–1.61 (m, 4H), 1.52–1.50 (m, 2H)","75.5 MHz, DMSO-d 6","163.9, 159.2, 156.9, 153.2, 152.3, 147.0, 141.3, 137.6, 135.6, 132.5, 131.8, 131.0, 130.8, 129.8, 129.4, 129.0, 128.2, 125.8, 124.2, 124.2, 122.2, 120.2, 119.8, 119.4, 116.5, 101.8, 50.5, 46.7, 28.2, 25.5, 23.9, 16.8",34956887.0,Front Oncol. 2021 Dec 9; 11:768022,Front Oncol,2021.0,CC BY,2021-12-27 23:17:01,no
PMC10068431,"3.3.1.1 3,5-Dimethyl-4-phenyl-1,4,7,8-tetrahydrodipyrazolo[3,4-b:4′,3′-e] pyridine (5a) FT-IR (KBr) νmax: 3540, 3301, 2925, 1614, 1515, 1375 cm−1; 1H-NMR (300 MHz, DMSO-d6): δH (ppm) = 2.06 (6H, 2-CH3, singlet), 4.81 (1H, –CH, singlet), 7.14–7.20 (5H, H-aromatic, multi), 11.24–11.32 (3H, –NH, broad singlet); 13C NMR (75 MHz, DMSO-d6): δ (ppm) = 10.8, 33.1, 104.6, 125.8, 127.9, 128.1, 140.2, 143.7, 161.5. CHN Anal. Calcd for C15H15N5: C: 67.90, H: 5.70, N: 26.40 found C: 67.86, H: 5.67, N: 26.37, mass for C15H15N5: [M–H] 265.133 found 265.122.","3,5-Dimethyl-4-phenyl-1,4,7,8-tetrahydrodipyrazolo[3,4-b:4′,3′-e] pyridine",N/A,"1H-NMR (300 MHz, DMSO-d6): δH (ppm) = 2.06 (6H, 2-CH3, singlet), 4.81 (1H, –CH, singlet), 7.14–7.20 (5H, H-aromatic, multi), 11.24–11.32 (3H, –NH, broad singlet)","13C NMR (75 MHz, DMSO-d6): δ (ppm) = 10.8, 33.1, 104.6, 125.8, 127.9, 128.1, 140.2, 143.7, 161.5","300 MHz, DMSO-d6","2.06 (6H, 2-CH3, singlet), 4.81 (1H, –CH, singlet), 7.14–7.20 (5H, H-aromatic, multi), 11.24–11.32 (3H, –NH, broad singlet)","75 MHz, DMSO-d6","10.8, 33.1, 104.6, 125.8, 127.9, 128.1, 140.2, 143.7, 161.5",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6017028,"Methyl 2-((5-bromo-4-(3-pyridinylmethyl)-4H-1,2,4-triazol-3-yl)thio)acetate (7f): White solid; 7.55 g (55%); m.p. 68–70 °C. 1H-NMR (DMSO-d6, 400 MHz) δ: 8.54–8.56 (m, 1H), 8.51 (d, J = 1.6 Hz, 1H), 7.57–7.59 (m, 1H), 7.41–7.44 (m, 1H), 5.28 (s, 2H), 4.11 (s, 2H), 3.63 (s, 3H). 13C-NMR (DMSO-d6, 100 MHz) δ: 168.41, 151.45, 149.16, 148.17, 135.12, 130.56, 130.44, 123.98, 52.51, 45.89, 34.32.","Methyl 2-((5-bromo-4-(3-pyridinylmethyl)-4H-1,2,4-triazol-3-yl)thio)acetate",O=C(OC)CSC1=NN=C(Br)N1CC2=CC=CN=C2,"1H-NMR (DMSO-d6, 400 MHz) δ: 8.54–8.56 (m, 1H), 8.51 (d, J = 1.6 Hz, 1H), 7.57–7.59 (m, 1H), 7.41–7.44 (m, 1H), 5.28 (s, 2H), 4.11 (s, 2H), 3.63 (s, 3H)","13C-NMR (DMSO-d6, 100 MHz) δ: 168.41, 151.45, 149.16, 148.17, 135.12, 130.56, 130.44, 123.98, 52.51, 45.89, 34.32","DMSO-d6, 400 MHz","8.54–8.56, 8.51, 7.57–7.59, 7.41–7.44, 5.28, 4.11, 3.63","DMSO-d6, 100 MHz","168.41, 151.45, 149.16, 148.17, 135.12, 130.56, 130.44, 123.98, 52.51, 45.89, 34.32",29382075.0,Molecules. 2018 Jan 27; 23(2):252,Molecules,2018.0,CC BY,2021-01-05 19:29:17,no
PMC4964411,"5-((R)-1,2-Dithiolan-3-yl)-N-(2-((S)-2-(6-methoxynaphthalen-2-yl)propanamido)ethyl)pentanamide (AL4). Yield: 66%; Rf = 0.54, CHCl3/MeOH (95:5); 1H-NMR (300.2 MHz, CDCl3) δ: 1.23–3.13 (15H, m), 3.28–3.33 (4H, m), 3.46–3.55 (1H, m), 3.65–3.71 (1H, m), 3.91 (3H, s), 6.04 (1H, br, s), 6.06 (1H, br, s), 7.11–7.73 (6H, m); 13C-NMR (75.48 MHz, CDCl3) δ: 18.6, 25.4, 29.1, 34.8, 36.4, 38.7, 40.2, 40.4, 40.5, 47.2, 55.6, 56.7, 105.8, 119.5, 126.3, 127.8, 129.2, 129.5, 129.5, 134.0, 136.5, 158.0, 173.9, 176.1; HR-MS (ESI) m/z 461.1922 [M + H]+.","5-((R)-1,2-Dithiolan-3-yl)-N-(2-((S)-2-(6-methoxynaphthalen-2-yl)propanamido)ethyl)pentanamide",O=C(NCCNC([C@H](C1=CC=C2C=C(OC)C=CC2=C1)C)=O)CCCC[C@H]3SSCC3,"1H-NMR (300.2 MHz, CDCl3) δ: 1.23–3.13 (15H, m), 3.28–3.33 (4H, m), 3.46–3.55 (1H, m), 3.65–3.71 (1H, m), 3.91 (3H, s), 6.04 (1H, br, s), 6.06 (1H, br, s), 7.11–7.73 (6H, m)","13C-NMR (75.48 MHz, CDCl3) δ: 18.6, 25.4, 29.1, 34.8, 36.4, 38.7, 40.2, 40.4, 40.5, 47.2, 55.6, 56.7, 105.8, 119.5, 126.3, 127.8, 129.2, 129.5, 129.5, 134.0, 136.5, 158.0, 173.9, 176.1","300.2 MHz, CDCl3","1.23–3.13 (15H, m), 3.28–3.33 (4H, m), 3.46–3.55 (1H, m), 3.65–3.71 (1H, m), 3.91 (3H, s), 6.04 (1H, br, s), 6.06 (1H, br, s), 7.11–7.73 (6H, m)","75.48 MHz, CDCl3","18.6, 25.4, 29.1, 34.8, 36.4, 38.7, 40.2, 40.4, 40.5, 47.2, 55.6, 56.7, 105.8, 119.5, 126.3, 127.8, 129.2, 129.5, 129.5, 134.0, 136.5, 158.0, 173.9, 176.1",27376271.0,Int J Mol Sci. 2016 Jun 30; 17(7):1035,Int J Mol Sci,2016.0,CC BY,2021-01-05 06:55:21,no
PMC6669684,"(S)-methyl 2-acetamido-4-(2-(methylamino)phenyl)-4-oxobutanoate (1)—white powder; [α]D20 +58.1 (c 0.1, CHCl3); UV (MeOH) λmax(log ε) 383 (3.16), 259 (3.31), 228 (3.79), 202 (3.69) nm, 1H NMR (DMSO-d6, 700 MHz), and 13C NMR (DMSO-d6, 175 MHz), Table 1; HR–ESI–MS m/z 301.1155 [M + Na]+ (calcd. for C14H18N2NaO4, 301.1159) and 279.1336 [M + H]+ (calcd. for C14H19N2O4, 279.1339). ",(S)-methyl 2-acetamido-4-(2-(methylamino)phenyl)-4-oxobutanoate,O=C(OC)[C@@H](NC(C)=O)CC(C1=CC=CC=C1NC)=O,"1H NMR (DMSO-d6, 700 MHz), and 13C NMR (DMSO-d6, 175 MHz), Table 1","1H NMR (DMSO-d6, 700 MHz), and 13C NMR (DMSO-d6, 175 MHz), Table 1","DMSO-d6, 700 MHz",N/A,"DMSO-d6, 175 MHz",N/A,31284448.0,Mar Drugs. 2019 Jul 5; 17(7):398,Mar Drugs,2019.0,CC BY,2021-01-06 03:10:53,no
PMC10026555,"3.3.1 S-Phenyl-3-(phenylthio)propanethioate Yellow oil, 0.236 g, 86% yield. 1H-NMR (400 MHz, CDCl3), δ(ppm): 7.44–7.42 (m, 7H, Ar), 7.36 (t, J = 7.2 Hz, 2H, Ar), 7.27 (t, J = 7.2 Hz, 1H, Ar), 3.27 (t, J = 7.6 Hz, 2H, CH2), 2.99 (t, J = 7.6 Hz, 2H, CH2). 13C-NMR (100 MHz, CDCl3), δ(ppm): 195.7, 134.9, 134.5, 130.2, 129.6, 129.2, 129.1, 127.2, 126.7, 43.2, 29.2. Anal. calcd for C15H14OS2: C, 65.66; H, 5.14; S, 23.37. Found: C, 65.79; H, 5.21; S, 23.25 (Table 2, entry 1).13",S-Phenyl-3-(phenylthio)propanethioate,O=C(SC1=CC=CC=C1)CCSC2=CC=CC=C2,"1H-NMR (400 MHz, CDCl3), δ(ppm): 7.44–7.42 (m, 7H, Ar), 7.36 (t, J = 7.2 Hz, 2H, Ar), 7.27 (t, J = 7.2 Hz, 1H, Ar), 3.27 (t, J = 7.6 Hz, 2H, CH2), 2.99 (t, J = 7.6 Hz, 2H, CH2)","13C-NMR (100 MHz, CDCl3), δ(ppm): 195.7, 134.9, 134.5, 130.2, 129.6, 129.2, 129.1, 127.2, 126.7, 43.2, 29.2","400 MHz, CDCl3","7.44–7.42 (m, 7H, Ar), 7.36 (t, J = 7.2 Hz, 2H, Ar), 7.27 (t, J = 7.2 Hz, 1H, Ar), 3.27 (t, J = 7.6 Hz, 2H, CH2), 2.99 (t, J = 7.6 Hz, 2H, CH2)","100 MHz, CDCl3","195.7, 134.9, 134.5, 130.2, 129.6, 129.2, 129.1, 127.2, 126.7, 43.2, 29.2",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6225319,"3.3. Characterization Data 3-(3-(Benzylamino)propyl)indolin-2-one (1a): Yellow oil. 1H-NMR (300 MHz, CDCl3) δ 8.47 (br, 1H), 7.31–7.30 (m, 4H), 7.24–7.16 (m, 3H), 7.03–6.98 (t, J = 7.5, 1H), 6.86–6.84 (d, J = 7.5 Hz, 1H), 3.78 (s, 2H), 3.49–3.45 (t, J = 6.0 Hz, 1H), 2.68–2.63 (m, 2H), 2.49 (br, 1H), 2.05–1.98 (dd, J = 14.1, 8.1 Hz, 2H), 1.66–1.53 (m, 2H). 13C-NMR (126 MHz, DMSO-d6) δ 178.7, 142.7, 136.2, 129.4, 129.0, 128.3, 127.7, 127.6, 124.0, 121.2, 109.2, 51.3, 47.3, 44.7, 27.2, 23.6. IR νmax (KBr, film, cm−1): 3203, 3061, 2929, 2856, 1683, 1471, 751. HRMS (ESI): calcd for C18H21ON2+ [M + H]+: 281.1648, found: 281.1647.",3-(3-(Benzylamino)propyl)indolin-2-one,O=C1NC2=C(C=CC=C2)C1CCCNCC3=CC=CC=C3,"1H-NMR (300 MHz, CDCl3) δ 8.47 (br, 1H), 7.31–7.30 (m, 4H), 7.24–7.16 (m, 3H), 7.03–6.98 (t, J = 7.5, 1H), 6.86–6.84 (d, J = 7.5 Hz, 1H), 3.78 (s, 2H), 3.49–3.45 (t, J = 6.0 Hz, 1H), 2.68–2.63 (m, 2H), 2.49 (br, 1H), 2.05–1.98 (dd, J = 14.1, 8.1 Hz, 2H), 1.66–1.53 (m, 2H)","13C-NMR (126 MHz, DMSO-d6) δ 178.7, 142.7, 136.2, 129.4, 129.0, 128.3, 127.7, 127.6, 124.0, 121.2, 109.2, 51.3, 47.3, 44.7, 27.2, 23.6","300 MHz, CDCl3","8.47 (br, 1H), 7.31–7.30 (m, 4H), 7.24–7.16 (m, 3H), 7.03–6.98 (t, J = 7.5, 1H), 6.86–6.84 (d, J = 7.5 Hz, 1H), 3.78 (s, 2H), 3.49–3.45 (t, J = 6.0 Hz, 1H), 2.68–2.63 (m, 2H), 2.49 (br, 1H), 2.05–1.98 (dd, J = 14.1, 8.1 Hz, 2H), 1.66–1.53 (m, 2H)","126 MHz, DMSO-d6","178.7, 142.7, 136.2, 129.4, 129.0, 128.3, 127.7, 127.6, 124.0, 121.2, 109.2, 51.3, 47.3, 44.7, 27.2, 23.6",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC7730743,"Ethyl (2′,3′,4′,6′-tetra-O-acetyl-α-d-mannopyranosyl)-(1→6)-2,3,4-tri-O-acetyl-1-thio-α-d-mannopyranoside (13) was hydrolyzed to the corresponding ethyl (2′,3′,4′,6′-tetra-O-acetyl-α-d-mannopyranosyl)-(1→6)-3,4-di-O-acetyl-1-thio-α-d-mannopyranoside (13a) following the general procedure for enzymatic hydrolysis: substrate (28 mg, 10 mM) was solubilized in 4.39 mL of phosphate buffer 50 mM pH 4.8 and 30% v/v of acetonitrile. The reaction was started through addition of AXE-GLX-AG (160 UI). The reaction mixture was monitored by TLC (dichloromethane/acetone 8:2, Rf = 0.62). Column chromatography (SiO2, dichloromethane/acetone 9:1) gave the desired product as a white solid (10 mg, 38%).  1H-NMR (400 MHz, CDCl3): δ 5.35 (m, 1H, H-1) 5.33-5.22 (m, 5H, H-4, H-4′, H-3′, H-2′,H-3,), 4.90 (d, 1H, J = 1.8 Hz, H-1′), 4.40 (ddd, 1H, J = 9.3, 6.5, 2.2 Hz, H-5), 4.26-4.14 (m, 3H, H-6′a, H-6′b, H-2) 4.11 (ddd, 1H, J = 9.7, 5.4, 2.4 Hz, 1H, H-5′), 3.83 (dd, 1H, J = 10.9, 6.6 Hz, H-6a), 3.57 (dd, 1H, J = 10.9, 2.2 Hz, H-6b), 2.75-2.59 (m, 2H, SCH2CH3), 2.17, 2.13, 2.10, 2.07, 2.06, 2.01 (6s, 18H, COCH3), 1.35 (t, 3H, J = 7.4, SCH2CH3). 13C-NMR (400 MHz, CDCl3): δ 170.82, 170.17, 169.94, 169.81, 169.81, 169.81 (6C, CH3COO), 97.39 (C-1′), 83.21 (C-1), 72.03, 70.64 (C-2), 69.61, 69.43 (C-5), 68.84, 68.53 (C-5′), 66.96, 66.47 (C-6), 66.15, 62.47 (C-6′), 24.79 (SCH2CH3), 20.90, 20.87, 20.78, 20.74, 20.70, 20.67 (6C, CH3COO), 14.56 (SCH2CH3).  MS: m/z = 661.22 [M + Na+] (calculated 661.18).",N/A,N/A,"1H-NMR (400 MHz, CDCl3): δ 5.35 (m, 1H, H-1) 5.33-5.22 (m, 5H, H-4, H-4′, H-3′, H-2′,H-3,), 4.90 (d, 1H, J = 1.8 Hz, H-1′), 4.40 (ddd, 1H, J = 9.3, 6.5, 2.2 Hz, H-5), 4.26-4.14 (m, 3H, H-6′a, H-6′b, H-2) 4.11 (ddd, 1H, J = 9.7, 5.4, 2.4 Hz, 1H, H-5′), 3.83 (dd, 1H, J = 10.9, 6.6 Hz, H-6a), 3.57 (dd, 1H, J = 10.9, 2.2 Hz, H-6b), 2.75-2.59 (m, 2H, SCH2CH3), 2.17, 2.13, 2.10, 2.07, 2.06, 2.01 (6s, 18H, COCH3), 1.35 (t, 3H, J = 7.4, SCH2CH3)","13C-NMR (400 MHz, CDCl3): δ 170.82, 170.17, 169.94, 169.81, 169.81, 169.81 (6C, CH3COO), 97.39 (C-1′), 83.21 (C-1), 72.03, 70.64 (C-2), 69.61, 69.43 (C-5), 68.84, 68.53 (C-5′), 66.96, 66.47 (C-6), 66.15, 62.47 (C-6′), 24.79 (SCH2CH3), 20.90, 20.87, 20.78, 20.74, 20.70, 20.67 (6C, CH3COO), 14.56 (SCH2CH3)","400 MHz, CDCl3","5.35 (m, 1H, H-1) 5.33-5.22 (m, 5H, H-4, H-4′, H-3′, H-2′,H-3,), 4.90 (d, 1H, J = 1.8 Hz, H-1′), 4.40 (ddd, 1H, J = 9.3, 6.5, 2.2 Hz, H-5), 4.26-4.14 (m, 3H, H-6′a, H-6′b, H-2) 4.11 (ddd, 1H, J = 9.7, 5.4, 2.4 Hz, 1H, H-5′), 3.83 (dd, 1H, J = 10.9, 6.6 Hz, H-6a), 3.57 (dd, 1H, J = 10.9, 2.2 Hz, H-6b), 2.75-2.59 (m, 2H, SCH2CH3), 2.17, 2.13, 2.10, 2.07, 2.06, 2.01 (6s, 18H, COCH3), 1.35 (t, 3H, J = 7.4, SCH2CH3)","400 MHz, CDCl3","170.82, 170.17, 169.94, 169.81, 169.81, 169.81, 97.39, 83.21, 72.03, 70.64, 69.61, 69.43, 68.84, 68.53, 66.96, 66.47, 66.15, 62.47, 24.79, 20.90, 20.87, 20.78, 20.74, 20.70, 20.67, 14.56",33297422.0,Molecules. 2020 Dec 7; 25(23):5764,Molecules,2020.0,CC BY,2021-01-30 02:44:31,no
PMC10180197,"7-phenyl-5-(thiophen-2-yl)-2-thioxo-2,3-dihydropyrido [2,3-d]pyrimidin-4(1H)-one (2c): The crude product was recrystallized from ethanol. Yield: 17%, brown solid, m.p.: 260–262 °C. IR (KBr, cm−1): 3061.5, 2907.6, 1691.4, 1555.1, 1170.9. 1H-NMR (500 MHz, DMSO-d6): δ 13.07 (br. s, 1H), 12.43 (br. s, 1H), 8.22 (dd, J = 6.4, 3.1 Hz, 2H), 7.77 (d, J = 5.0 Hz, 1H), 7.74 (s, 1H), 7.57–7.52 (m, 3H), 7.48 (d, J = 3.6 Hz, 1H), 7.17–7.14 (m, 1H). 13C-NMR (125 MHz, DMSO-d6): δ 175.3, 159.4, 158.7, 152.9, 146.2, 138.1, 136.3, 130.9, 130.2, 128.9, 128.8, 127.6, 126.9, 119.4, 107.6. LC-MS (ESI, m/z, MeOH): [M – H]− = 336, [M + Na]+ = 360, [M + K]+ = 376, [M + MeOH + Na]+ = 392. Elemental Analysis C, H, N. Calculated % (C17H11N3OS2): C: 60.51, H: 3.29, N: 12.46. Found % (C17H11N3OS2): 65.95, H: 3.31, N: 12.48.","7-phenyl-5-(thiophen-2-yl)-2-thioxo-2,3-dihydropyrido [2,3-d]pyrimidin-4(1H)-one",O=C(N1)C2=C(C3=CC=CS3)C=C(C4=CC=CC=C4)N=C2NC1=S,"1H-NMR (500 MHz, DMSO-d6): δ 13.07 (br. s, 1H), 12.43 (br. s, 1H), 8.22 (dd, J = 6.4, 3.1 Hz, 2H), 7.77 (d, J = 5.0 Hz, 1H), 7.74 (s, 1H), 7.57–7.52 (m, 3H), 7.48 (d, J = 3.6 Hz, 1H), 7.17–7.14 (m, 1H)","13C-NMR (125 MHz, DMSO-d6): δ 175.3, 159.4, 158.7, 152.9, 146.2, 138.1, 136.3, 130.9, 130.2, 128.9, 128.8, 127.6, 126.9, 119.4, 107.6","500 MHz, DMSO-d6","13.07 (br. s, 1H), 12.43 (br. s, 1H), 8.22 (dd, J = 6.4, 3.1 Hz, 2H), 7.77 (d, J = 5.0 Hz, 1H), 7.74 (s, 1H), 7.57–7.52 (m, 3H), 7.48 (d, J = 3.6 Hz, 1H), 7.17–7.14 (m, 1H)","125 MHz, DMSO-d6","175.3, 159.4, 158.7, 152.9, 146.2, 138.1, 136.3, 130.9, 130.2, 128.9, 128.8, 127.6, 126.9, 119.4, 107.6",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC10180063,"(2-Methyl-5,6-dihydropyrazolo[5,1-a]isoquinolin-1-yl)(phenyl)methanone (4at). Following the general procedure; flash chromatography (EtOAc:hexane = 2:3, 18 mg, yield 64%), white solid: m.p. 75–77 °C; 1H NMR (400 MHz, CDCl3) δ 7.89–7.79 (m, 2H), 7.58–7.49 (m, 1H), 7.44–7.37 (m, 2H), 7.36–7.31 (m, 1H), 7.26–7.17 (m, 2H), 7.04 (td, J = 7.6, 1.5 Hz, 1H), 4.32 (t, J = 6.9 Hz, 2H), 3.22 (t, J = 6.8 Hz, 2H), 2.19 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 193.1, 149.4, 139.5, 139.0, 133.08, 133.06, 129.8, 128.9, 128.7, 128.2, 127.2, 127.0, 126.0, 116.1, 46.4, 29.5, 13.7; IR (neat) 2972, 2901, 1612, 1596, 1578, 1531, 1487, 1477, 1423, 1394, 1349, 1340, 1314, 1276, 1254, 1195, 1137, 1026 cm−1; HRMS (EI) m/z calcd for [M]+ C19H16N2O: 288.1263, found: 288.1260.","(2-Methyl-5,6-dihydropyrazolo[5,1-a]isoquinolin-1-yl)(phenyl)methanone",N/A,"1H NMR (400 MHz, CDCl3) δ 7.89–7.79 (m, 2H), 7.58–7.49 (m, 1H), 7.44–7.37 (m, 2H), 7.36–7.31 (m, 1H), 7.26–7.17 (m, 2H), 7.04 (td, J = 7.6, 1.5 Hz, 1H), 4.32 (t, J = 6.9 Hz, 2H), 3.22 (t, J = 6.8 Hz, 2H), 2.19 (s, 3H)","13C NMR (100 MHz, CDCl3) δ 193.1, 149.4, 139.5, 139.0, 133.08, 133.06, 129.8, 128.9, 128.7, 128.2, 127.2, 127.0, 126.0, 116.1, 46.4, 29.5, 13.7","400 MHz, CDCl3","7.89–7.79 (m, 2H), 7.58–7.49 (m, 1H), 7.44–7.37 (m, 2H), 7.36–7.31 (m, 1H), 7.26–7.17 (m, 2H), 7.04 (td, J = 7.6, 1.5 Hz, 1H), 4.32 (t, J = 6.9 Hz, 2H), 3.22 (t, J = 6.8 Hz, 2H), 2.19 (s, 3H)","100 MHz, CDCl3","193.1, 149.4, 139.5, 139.0, 133.08, 133.06, 129.8, 128.9, 128.7, 128.2, 127.2, 127.0, 126.0, 116.1, 46.4, 29.5, 13.7",N/A,N/A,N/A,N/A,N/A,N/A,N/A
PMC6063323,"(S)-2-{[N-Benzyl-4-(2-fluoroethoxy)phenyl]sulfonamide}-4-fluoropent-4-enoic acid ((S)-7a) In a dried YOUNG-tube tert-butyl N-benzyl-(S)-N-[p-(2-fluoroethoxy)phenyl-sulfonyl]-2-amino-4-fluoropent-4-enoate ((S)-6a) (400 mg, 0.94 mmol) was dissolved in dry dichloromethane (20 mL) under argon and treated with trifluoroacetic acid (20 mL). The YOUNG-tube was flushed with argon and sealed. The mixture was stirred at rt. for 3–4 h. Subsequently the reaction mixture was evaporated to dryness in vacuum. The residue was dissolved in chloroform (100 mL) and washed with an aqueous solution of citric acid and sodium bicarbonate (25 mL, pH ≈ 4). The aqueous phase was extracted with chloroform (4 × 30 mL) and the combined organic phases were dried with magnesium sulfate. After evaporation of the solvent the crude product was obtained as colorless, viscos oils, which in high vacuum solidified. The product was used for the next step without further purification (160 mg, 40%). 1H NMR (300 MHz, CD3CN): δ = 7.78 (dm, 3JH,H = 9.1, ArH, 2H), 7.29 (m, ArH, ArH, ArH, 5H), 7.04 (dm, 3JH,H = 9.0 ArH, 2H,), 4.75 (dm, 2JH,F = 47.7 Hz, CH2F, 2H), 4.65 (dd, 3JH,H = 8.5, 3JH,H = 6.0, NCH, 1H), 4.57 (d, 2JH,H = 16.1, NCH2, HA, 1H), 4.52 (dd, 3JH,F = 17.6, 2JH,H = 3.0, CF=CH2, Hcis, 1H), 4.32 (d, 2JH,H = 16.1, NCH2, HB, 1H), 4.30 (dm, 3JH,F = 29.4 Hz, CH2CH2F, 2H), 4.14 (dd, 3JH,F = 51.8, 2JH,H = 3.4, CF=CH2, Htrans, 1H), 2.76 (ddd, 3JH,F = 14.7, 2JH,H = 13.7, 3JH,H = 6.0, NCH2, HA, 1H), 2.47 (ddd, 3JH,F = 22.2, 2JH,H = 15.4, 3JH,H = 8.5, NCH2, HB, 1H). 13C NMR (75 MHz, CD3CN): δ = 171.2 (CO), 163.2 (d, 1JC,F = 254.7 Hz, CF), 163.1 (ArCO), 138.2 (ArCCH2), 133.0 (ArCSO2), 131.0 (ArCH), 129.6 (ArCH), 129.3 (ArCH), 128.7 (ArCH), 115.7 (ArCH), 93.8 (d, 2JC,F = 18.9 Hz, CF=CH2), 83.1 (d, 1JC,F = 167.5 Hz, CH2F), 68.8 (d, 2JC,F = 19.2 Hz, CH2CH2F), 57.9 (NCH), 50.8 (NCH2), 34.2 (d, 2JC,F = 28.0 Hz, NCHCH2). 19F NMR (282 MHz, CD3CN): δ = − 97.7 (dddd, 3JH,F = 50.9 Hz, 3JH,F = 22.1 Hz, 3JH,F = 17.7 Hz, 3JH,F = 13.3 Hz, CF), − 224.0 (tt, 2JH,F = 47.7 Hz, 3JH,F = 29.5 Hz, CH2F). MS-ES(+)-EM: m/z = 448.1009 [(M + Na)+] calcd. For C20H31F2NO5SNa+: 448.1006.",(S)-2-{[N-Benzyl-4-(2-fluoroethoxy)phenyl]sulfonamide}-4-fluoropent-4-enoic acid,N/A,"1H NMR (300 MHz, CD3CN): δ = 7.78 (dm, 3JH,H = 9.1, ArH, 2H), 7.29 (m, ArH, ArH, ArH, 5H), 7.04 (dm, 3JH,H = 9.0 ArH, 2H,), 4.75 (dm, 2JH,F = 47.7 Hz, CH2F, 2H), 4.65 (dd, 3JH,H = 8.5, 3JH,H = 6.0, NCH, 1H), 4.57 (d, 2JH,H = 16.1, NCH2, HA, 1H), 4.52 (dd, 3JH,F = 17.6, 2JH,H = 3.0, CF=CH2, Hcis, 1H), 4.32 (d, 2JH,H = 16.1, NCH2, HB, 1H), 4.30 (dm, 3JH,F = 29.4 Hz, CH2CH2F, 2H), 4.14 (dd, 3JH,F = 51.8, 2JH,H = 3.4, CF=CH2, Htrans, 1H), 2.76 (ddd, 3JH,F = 14.7, 2JH,H = 13.7, 3JH,H = 6.0, NCH2, HA, 1H), 2.47 (ddd, 3JH,F = 22.2, 2JH,H = 15.4, 3JH,H = 8.5, NCH2, HB, 1H)","13C NMR (75 MHz, CD3CN): δ = 171.2 (CO), 163.2 (d, 1JC,F = 254.7 Hz, CF), 163.1 (ArCO), 138.2 (ArCCH2), 133.0 (ArCSO2), 131.0 (ArCH), 129.6 (ArCH), 129.3 (ArCH), 128.7 (ArCH), 115.7 (ArCH), 93.8 (d, 2JC,F = 18.9 Hz, CF=CH2), 83.1 (d, 1JC,F = 167.5 Hz, CH2F), 68.8 (d, 2JC,F = 19.2 Hz, CH2CH2F), 57.9 (NCH), 50.8 (NCH2), 34.2 (d, 2JC,F = 28.0 Hz, NCHCH2)","300 MHz, CD3CN","7.78 (dm, 3JH,H = 9.1, ArH, 2H), 7.29 (m, ArH, ArH, ArH, 5H), 7.04 (dm, 3JH,H = 9.0 ArH, 2H,), 4.75 (dm, 2JH,F = 47.7 Hz, CH2F, 2H), 4.65 (dd, 3JH,H = 8.5, 3JH,H = 6.0, NCH, 1H), 4.57 (d, 2JH,H = 16.1, NCH2, HA, 1H), 4.52 (dd, 3JH,F = 17.6, 2JH,H = 3.0, CF=CH2, Hcis, 1H), 4.32 (d, 2JH,H = 16.1, NCH2, HB, 1H), 4.30 (dm, 3JH,F = 29.4 Hz, CH2CH2F, 2H), 4.14 (dd, 3JH,F = 51.8, 2JH,H = 3.4, CF=CH2, Htrans, 1H), 2.76 (ddd, 3JH,F = 14.7, 2JH,H = 13.7, 3JH,H = 6.0, NCH2, HA, 1H), 2.47 (ddd, 3JH,F = 22.2, 2JH,H = 15.4, 3JH,H = 8.5, NCH2, HB, 1H)","75 MHz, CD3CN","171.2, 163.2, 163.1, 138.2, 133.0, 131.0, 129.6, 129.3, 128.7, 115.7, 93.8, 83.1, 68.8, 57.9, 50.8, 34.2",30101186.0,EJNMMI Radiopharm Chem. 2018 Jul 27; 3:10,EJNMMI Radiopharm Chem,2018.0,CC BY,2021-01-05 20:15:49,no
